N (2010-2017)

STUDIES ON CONDITIONS and RELATED ARTICLES 2010-2017


+Studies in 2000-2009 List
*Studies in Pre-2000 List

NAIL-PATELLA SYNDROME + (See News Articles 2010-2017)
NARCOLEPSY
NAUSEA*+ (See Also MORNING SICKNESS, MOTION SICKNESS, RADIATION-INDUCED NAUSEA)
NEOINTIMA (Thickening of Arterial Walls)
NEUROGENESIS (Formation of New Neurons)
NEUROMYELITIS OPTICA/DEVICA’S DISEASE (Disorder Causing Swelling of Eye Nerves)
NEURONS/BRAIN CELLS*+
NEUROPATHIC PAIN*+
NEUROPROTECTION*+
NIEMANN-PICK DISEASE (See Pre-2000 List)
NUTRITION-GENERAL*+ (See Also OMEGA-3/CB1 CONNECTION, METHODS OF USE-EDIBLES)
NUTRITION-HEMP SEED*+
NUTRITION-HEMP SEED OIL*+ (See Also OMEGA-3/CB1 CONNECTION)
NUTRITION-HEMP SEED PROTEIN ISOLATES/POWDERS


NARCOLEPSY
Marijuana helps narcolepsy (case report–undated) http://cannabisclinicians.org/view-all-case-reports/entry/598/?pagenum=2


NAUSEA
Regulation of nausea and vomiting by cannabinoids (full–2010) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2010.01176.x/pdf
Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2997305/pdf/bcp0070-0656.pdf
Motion Sickness, Stress and the Endocannabinoid System (abst–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873996/?toolmcentrez
Cannabinoid-Induced Hyperemesis: A Conundrum—From Clinical Recognition to Basic Science Mechanisms (full-2010) http://www.mdpi.com/1424-8247/3/7/2163/htm
Mechanisms of Broad-Spectrum Antiemetic Efficacy of Cannabinoids against Chemotherapy-Induced Acute and Delayed Vomiting (link to PDF-2010) http://www.mdpi.com/1424-8247/3/9/2930
Pharmacology and toxicology of Cannabis derivatives and endocannabinoid agonists (link to PDF–2010) http://www.eurekaselect.com/85221/article
The abuse potential of the synthetic cannabinoid nabilone (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20402993
Cannabidiol, a Non-Psychotropic Component of Cannabis, Attenuates Vomiting and Nausea-like Behaviour via Indirect Agonism of 5-HT(1A) Somatodendritic: Auto-receptors in the Dorsal Raphe Nucleus (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423241/
Regulation of nausea and vomiting by cannabinoids (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165951/
The intersection between cannabis and cancer in the United States (full–2011) http://www.croh-online.com/article/S1040-8428(11)00231-9/fulltext
Medical Marijuana: Can Pot Help Pregnant Women With Vomiting and Nausea? (article–2011) http://patients4medicalmarijuana.wordpress.com/2011/01/13/pregnancy-and-medical-marijuana-can-pothelp-pregnant-women-with-vomiting-and-nausea/
Interaction between non-psychotropic cannabinoids in marihuana: effect of cannabigerol (CBG) on the anti-nausea or anti-emetic effects of cannabidiol (CBD) in rats and shrews (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21243485
Medical cannabis: the opportunity versus the temptation (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22352284
Medical Marijuana: Clearing Away the Smoke (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3358713/
top
Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid? (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579248/
The anti-nausea effects of CB(1) agonists are mediated by an action at the visceral insular cortex (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492992/
The Therapeutic Potential of Cannabis and Cannabinoids (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442177/
Tumor necrosis factor activation of vagal afferent terminal calcium is blocked by cannabinoids (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342927/
Inhibition of monoacylglycerol lipase attenuates vomiting in Suncus murinus and 2-arachidonoyl glycerol attenuates nausea in rats (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423233/
Cannabinoids in the treatment of chemotherapy-induced nausea and vomiting (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22491047
Effects of parabolic flight and spaceflight on the endocannabinoid system in humans (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23023882
Effects of dronabinol on morphine-induced dopamine-related behavioral effects in animals (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22807156
Cannabidiolic acid prevents vomiting in Suncus murinus and nausea-induced behaviour in rats by enhancing 5-HT(1A) receptor activation (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596650/
Effect of low doses of cannabidiolic acid and ondansetron on LiCl-induced conditioned gaping (a model of nausea-induced behaviour) in rats (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3682714/
Evaluation of the potential of the phytocannabinoids, cannabidivarin (CBDV) and Δ9 -tetrahydrocannabivarin (THCV), to produce CB1 receptor inverse agonism symptoms of nausea in rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23902479
Anandamide transport inhibition by ARN272 attenuates nausea-induced behaviour in rats, and vomiting in shrews (Suncus murinus) (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23991698
Regulation of nausea and vomiting by cannabinoids and the endocannabinoid system (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24184696
Tetrahydrocannabinolic acid reduces nausea-induced conditioned gaping in rats and vomiting in Suncus murinus (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23889598
The Medical Necessity for Medicinal Cannabis: Prospective, Observational Study Evaluating the Treatment in Cancer Patients on Supportive or Palliative Care (full–2013) http://cannabisclinicians.org/wp-content/uploads/2013/09/Med-Nec-for-Cannabis-in-Cancer-Israel.pdf
Dronabinol Treatment of Refractory Nausea and Vomiting Related to Peritoneal Carcinomatosis (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24052427
Therapeutic potential of cannabinoid medicines (full–2013) http://onlinelibrary.wiley.com/doi/10.1002/dta.1529/full
Additive antiemetic efficacy of 9-THC with vanilloid TRPV1 receptor agonists in the least shrew (Cryptotis parva) (abst–2013) http://www.fasebj.org/cgi/content/meeting_abstract/27/1_MeetingAbstracts/1093.20?sid=eea722c0-971c-4daa-8b8c-38c0c63c19ad
Additive antiemetic efficacy of low-doses of the cannabinoid CB1/2 receptor agonist Δ9-THC with ultralow-doses of the vanilloid TRPV1 receptor agonist resiniferatoxin in the least shrew (Cryptotis parva) (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24157976
top
2-arachidonoylglycerol interferes with lithium-induced vomiting in the house musk shrew, Suncus murinus (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23958470
Suppression of lithium chloride-induced conditioned gaping (a model of nausea-induced behaviour) in rats (using the taste reactivity test) with metoclopramide is enhanced by cannabidiolic acid (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24012649
Nabilone for Non-chemotherapy Associated Nausea and Weight Loss due to Medical
Conditions: A Review of the Clinical Effectiveness and Guidelines [Internet] (full–2014) http://www.ncbi.nlm.nih.gov/books/NBK253668/toc/?report=reader
Medical marijuana for cancer (full–2014) http://onlinelibrary.wiley.com/doi/10.3322/caac.21260/full
Toward modulation of the endocannabinoid system for treatment of gastrointestinal disease: FAAHster but not “higher” (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24641009
Toward modulation of the endocannabinoid system for treatment of gastrointestinal disease: FAAHster but not “higher” (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/nmo.12329/full
Medical marijuana: more questions than answers (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25226202
Medical marijuana: more questions than answers (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4243838/
K2-Not the Spice of Life; Synthetic Cannabinoids and ST Elevation Myocardial Infarction: A Case Report (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4371021/
Dexamethasone alleviates motion sickness in rats in part by enhancing the endo-cannabinoid system (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24508383
A comparison of cannabidiolic acid with other treatments for anticipatory nausea using a rat model of contextually elicited conditioned gaping (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24595502
Meta-analysis of adjunctive non-NK1 receptor antagonist medications for the control of acute and delayed chemotherapy-induced nausea and vomiting (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25145507
Effect of selective inhibition of monoacylglycerol lipase (MAGL) on acute nausea, anticipatory nausea, and vomiting in rats and Suncus murinus (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25085768
Therapeutic Potential of Cannabinoids in Counteracting Chemotherapy-induced Adverse Effects: An Exploratory Review (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25504799
Therapeutic Potential of Cannabinoids in Counteracting Chemotherapy-induced Adverse Effects: An Exploratory Review (full–2014) http://onlinelibrary.wiley.com/doi/10.1002/ptr.5265/full
Potential applications of marijuana and cannabinoids in medicine (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25518584
The successful use of dronabinol for failure to thrive secondary to intestinal dysmotility (full–2015) http://www.casereports.com/article/S2210-2612%2815%2900219-9/pdf
Cannabis in cancer care (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/cpt.108/full
top
Cannabinoid hyperemesis syndrome: Marijuana is both antiemetic and proemetic (full–2015) http://www.ccjm.org/index.php?id=107953&tx_ttnews%5Btt_news%5D=412809&cHash=0c1f8670f2fa499ee88aeff79ee2a47e
Cannabinoids for Medical Use A Systematic Review and Meta-analysis (full–2015) http://jama.jamanetwork.com/article.aspx?articleid=2338251&resultClick=24
Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders (full–2015)
http://ascpjournal.biomedcentral.com/articles/10.1186/s13722-015-0032-7
Novel associations between FAAH genetic variants and postoperative central opioid related adverse effects (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25558980
Medical Marijuana: Is the Cart Before the Horse? (1st page–2015) http://jama.jamanetwork.com/article.aspx?articleid=2338230
Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26561338
Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD009464.pub2/full
Medical marijuana: Hints of headway? Despite a conflicted regulatory landscape, support for medical marijuana is growing amid increasing evidence of potential benefits (Part 2 of 2) (article–2015) http://onlinelibrary.wiley.com/doi/10.1002/cncy.21524/full
Intra-visceral insular cortex 2-arachidonoylglycerol, but not N arachidonoylethanolamide, suppresses acute nausea-induced conditioned gaping in rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25499318
The role of cannabinoids in regulation of nausea and vomiting, and visceral pain (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25715910
Cannabinoids suppress acute and anticipatory nausea in pre-clinical rat models of conditioned gaping (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25691302
Synergy between cannabidiol, cannabidiolic acid, and Δ⁹-tetrahydrocannabinol in the regulation of emesis in the Suncus murinus (house musk shrew) (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26030435
Interference with acute nausea and anticipatory nausea in rats by fatty acid amide hydrolase (FAAH) inhibition through a PPARα and CB1 receptor mechanism, respectively: a double dissociation (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26297326
Cannabis – therapy for the future? (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26375695
Effect of combined doses of Δ9-tetrahydrocannabinol (THC) and cannabidiolic acid (CBDA) on acute and anticipatory nausea using rat (Sprague- Dawley) models of conditioned gaping (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26381155
top
Neuromotor tolerability and behavioural characterisation of cannabidiolic acid, a phytocannabinoid with therapeutic potential for anticipatory nausea (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26439367
Endocannabinoid regulation of nausea is mediated by 2-arachidonoylglycerol (2-AG) in the rat visceral insular cortex (abst–2015) http://www.sciencedirect.com/science/article/pii/S0028390815301623
Controlled release tablet formulation containing natural δ9 tetrahydrocannabinol (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26585693
Endocannabinoid Mechanisms Influencing Nausea (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26638766
Intravenous Delta-9-Tetrahydrocannabinol to Prevent Postoperative Nausea and Vomiting: A Randomized Controlled Trial (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26426861
Cannabis and cancer: toward a new understanding (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791146/
Integrating cannabis into clinical cancer care (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791148/
Dronabinol for chemotherapy-induced nausea and vomiting unresponsive to antiemetics (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869612/
The Gut-Itch Connection (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/exd.12994/full
The involvement of TRPV1 in emesis and anti-emesis (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4843889/
A user’s guide to cannabinoid therapies in oncology (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5176373/
Cannabis and Cannabinoids (PDQ®)Health Professional Version (full–2016) https://www.ncbi.nlm.nih.gov/books/NBK65755/
Getting into the weed: the role of the endocannabinoid system in the brain-gut axis (link to full via ELSEVIER–2016) http://www.ncbi.nlm.nih.gov/pubmed/27133395
Using Medical Cannabis in an Oncology Practice (article–2016) (needs free registration) http://www.cancernetwork.com/oncology-journal/using-medical-cannabis-oncologypractice#sthash.CjT8fR9n.uWvEhfSG.dpuf
Using Medical Cannabis in an Oncology Practice (1st page–2016) http://www.cancernetwork.com/oncology-journal/using-medical-cannabis-oncologypractice#sthash.CjT8fR9n.dpuf
Cannabis and Cannabinoids (1st page–2016) http://jamanetwork.com/journals/jama/article-abstract/2592497
Medical use of cannabis products : Lessons to be learned from Israel and Canada (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26767992
Adverse effects after the use of JWH-210 – a case series from the EU Spice II plus project (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26768345
Neuromotor tolerability and behavioural characterisation of cannabidiolic acid, a phytocannabinoid with therapeutic potential for anticipatory nausea (abst–2016) http://link.springer.com/article/10.1007/s00213-015-4100-1
Efficacy, tolerability, and safety of cannabinoids in gastroenterology : A systematic review (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26809974
Elevation of 2-AG by monoacylglycerol lipase inhibition in the visceral insular cortex interferes with anticipatory nausea in a rat model (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26974857
A comparison of novel, selective fatty acid amide hydrolase (FAAH), monoacyglycerol lipase (MAGL) or dual FAAH/MAGL inhibitors to suppress acute and anticipatory nausea in rat models (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27048155
Cannabinoid 2 (CB2) receptor agonism reduces lithium chloride-induced vomiting in Suncus murinus and nausea-induced conditioned gaping in rats (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27263826
Cannabinoids for Symptom Management and Cancer Therapy: The Evidence (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27407130
Effect of combined oral doses of Δ9-tetrahydrocannabinol (THC) and cannabidiolic acid (CBDA) on acute and anticipatory nausea in rat models (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27438607
Hypophosphatemia in Users of Cannabis (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27692442
Novel Treatments for Cyclic Vomiting Syndrome: Beyond Ondansetron and Amitriptyline (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27757817
Role of cannabis in digestive disorders (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27792038
Experts’ Perspectives on the Role of Medical Marijuana in Oncology: a semi-structured interview study (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28040884


NEOINTIMA
Targeting cannabinoid receptor CB2 in cardiovascular disorders: promises and controversies (full–2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02042.x/pdf
Cannabinoid receptor CB2 protects against balloon-induced neointima formation (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3774259/
Endogenous cannabinoid receptor CB1 activation promotes vascular smooth muscle cell proliferation and neointima formation (full–2013) http://www.jlr.org/content/early/2013/03/11/jlr.M035147.long
Magnolol inhibits migration of vascular smooth muscle cells via cytoskeletal remodeling pathway to attenuate neointima formation (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23906924
top


NEUROGENESIS
Cannabinoid receptor CB1 mediates baseline and activity-induced survival of new neurons in adult hippocampal neurogenesis (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2898685/?tool=pmcentrez
Loss of retrograde endocannabinoid signaling and reduced adult neurogenesis in diacylglycerol lipase knock-out mice (full-2010) http://www.jneurosci.org/content/30/6/2017.long
Converging action of alcohol consumption and cannabinoid receptor activation on adult hippocampal neurogenesis (full–2010) http://ijnp.oxfordjournals.org/content/13/2/191.long
CB1 receptor deficiency decreases wheel-running activity: consequences on emotional behaviours and hippocampal neurogenesis (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20138171
Cannabidiol Reduces Aβ-Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARγ Involvement (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3230631/?tool=pubmed
CB2 Cannabinoid Receptors Promote Neural Progenitor Cell Proliferation via mTORC1 Signaling (full–2011) http://www.jbc.org/content/287/2/1198.full
EFFECT OF CANNABIS SATIVA ALCOHOLIC EXTRACT ON HIPPOCAMPUS NEURONAL DENSITY IN RATS (abst–2011) http://en.journals.sid.ir/ViewPaper.aspx?ID=258946
Can the benefits of cannabinoid receptor stimulation on neuroinflammation, neurogenesis and memory during normal aging be useful in AD prevention? (full–2012) http://www.jneuroinflammation.com/content/9/1/10
Endocannabinoids via CB₁ receptors act as neurogenic niche cues during cortical development (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3229.long
Relationships between dietary macronutrients and adult neurogenesis in the regulation of energy metabolism (full–2013) http://journals.cambridge.org/action/displayFulltext?type=6&fid=8904779&jid=BJN&volumeId=109&issueId=09&aid=8904778&bodyId=&membershipNumber=&societyETOCSession=&fulltextType=RV&fileId=S000711451200579X
Cannabinoids, Neurogenesis and Antidepressant Drugs: Is there a Link? (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3648779/
Activation of Type 1 Cannabinoid Receptor (CB1R) Promotes Neurogenesis in Murine Subventricular Zone Cell Cultures (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0063529
The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23298518
Neuroimmmune interactions of cannabinoids in neurogenesis: focus on interleukin-1β (IL-1β) signalling (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24256257
top
CB2 cannabinoid agonist enhanced neurogenesis in GFAP/Gp120 transgenic mice displaying deficits in neurogenesis (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24148086
High hopes for CB(2) receptors in neurogenesis (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/bph.12548/full
The cannabinoid CB2 receptor agonist AM1241 enhances neurogenesis in GFAP/Gp120 transgenic mice displaying deficits in neurogenesis (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/bph.12478/full
Impaired Neurogenesis by HIV-1-Gp120 is Rescued by genetic deletion of Fatty Acid Amide Hydrolase Enzyme (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24571443
Impaired Neurogenesis by HIV-1-Gp120 is Rescued by genetic deletion of Fatty Acid Amide Hydrolase Enzyme (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4594266/
Nutritional omega-3 modulates neuronal morphology in the prefrontal cortex along with depression-related behaviour through corticosterone secretion (full–2014) http://www.nature.com/tp/journal/v4/n9/full/tp201477a.html
Blockade of 2-arachidonoylglycerol hydrolysis produces antidepressant-like effects and enhances adult hippocampal neurogenesis and synaptic plasticity (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/hipo.22344/full
Potential Therapeutical Contributions of the Endocannabinoid System towards Aging and Alzheimer’s Disease (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567222/
Programming and reprogramming neural cells by (endo-) cannabinoids: from physiological rules to emerging therapies (full–2014) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4765324/
Pharmacological activation of CB2 receptors counteracts the deleterious effect of ethanol on cell proliferation in the main neurogenic zones of the adult rat brain (full–2015) http://journal.frontiersin.org/article/10.3389/fncel.2015.00379/full
The role of cannabinoids in adult neurogenesis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25951750
Influence of single and repeated cannabidiol administration on emotional behavior and markers of cell proliferation and neurogenesis in non-stressed mice (abst–2015) http://www.sciencedirect.com/science/article/pii/S027858461530004X
ACEA (a highly selective cannabinoid CB1 receptor agonist) stimulates hippocampal neurogenesis in mice treated with antiepileptic drugs (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26225920
Ultra-low doses of tetrahydrocannabinol contribute to the survival of newly-born cells in the dentate gyrus of adult rats (abst–2015) http://link.springer.com/article/10.1134/S1819712415030046
Cannabidiol, neuroprotection and neuropsychiatric disorders (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816000396 Immunohistochemical distribution of the cannabinoid receptor 1 and fatty acid amide hydrolase in the dog claustrum (abst–2016) http://www.sciencedirect.com/science/article/pii/S0891061815300405
Functional effects of cannabinoids during dopaminergic specification of human neural precursors derived from induced pluripotent stem cells (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27027565
Distinctive effects of eicosapentaenoic and docosahexaenoic acids in regulating neural stem cell fate are mediated via endocannabinoid signalling pathways (abst–2016) http://www.sciencedirect.com/science/article/pii/S0028390816301277
Cannabinoid receptor signaling induces proliferation but not neurogenesis in the mouse olfactory epithelium (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27606334 Restricted vs. unrestricted wheel running in mice: Effects on brain, behavior and endocannabinoids (abst–2016) http://www.sciencedirect.com/science/article/pii/S0018506X16301799
Cannabidiol reduces neuroinflammation and promotes neuroplasticity and functional recovery after brain ischemia (abst–2016) http://www.sciencedirect.com/science/article/pii/S0278584616302524
Cannabinoid Type-2 Receptor Drives Neurogenesis and Improves Functional Outcome After Stroke (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27899748
Cannabidiol Activates Neuronal Precursor Genes in Human Gingival Mesenchymal Stromal Cells (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27918106


NEUROMYELITIS OPTICA/DEVICA’S DISEASE
The major brain endocannabinoid 2-AG controls neuropathic pain and mechanical hyperalgesia in patients with neuromyelitis optica (full–2012) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0071500
top


NEURONS/BRAIN CELLS
Cyclooxygenase-2 Mediates Anandamide Metabolism in the Mouse Brain (full–2010) http://jpet.aspetjournals.org/content/335/2/380.full?sid=af53ea87-ab4b-426e-9c7e-8f750e9c4a17
Cannabinoids Excite Circadian Clock Neurons (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2927117/?tool=pmcentrez
Cannabinoid receptor CB1 mediates baseline and activity-induced survival of new neurons in adult hippocampal neurogenesis (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2898685/?tool=pmcentrez
Delta9-tetrahydrocannabinol is a full agonist at CB1 receptors on GABA neuron axon terminals in the hippocampus (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2882293/pdf/nihms200194.pdf
AAV vector-mediated overexpression of CB1 cannabinoid receptor in pyramidal neurons of the hippocampus protects against seizure-induced excitoxicity (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3006205/?tool=pubmed
Sex difference in cell proliferation in developing rat amygdala mediated by endocannabinoids has implications for social behavior (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2996668/?tool=pubmed
CB1 cannabinoid receptors increase neuronal precursor proliferation through AKT / glycogen synthase kinase-3beta/beta-catenin signaling (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2843172/?tool=pubmed
Converging action of alcohol consumption and cannabinoid receptor activation on adult hippocampal neurogenesis (full–2010) http://ijnp.oxfordjournals.org/content/13/2/191.long
Endocannabinoids Prevent β-Amyloid-mediated Lysosomal Destabilization in Cultured Neurons (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2992287/
The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2970523/
Regulatory Role of Cannabinoid Receptor 1 in Stress-Induced Excitotoxicity and Neuroinflammation (full-2010) http://www.nature.com/npp/journal/vaop/ncurrent/full/npp2010214a.html
Endocannabinoids: Going retro with DAGLα (article–2010) http://www.lipidmaps.org/update/2010/100401/full/nrn2824.html?s=cannabinoid
Effects of caffeine on striatal neurotransmission: focus on cannabinoid CB1 receptors (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20087854
Palmitoylethanolamide and other anandamide congeners. Proposed role in the diseased brain (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20353771
PP-014 Control of receptor expression in vagal afferent neurons by activation of cannabinoid 1 receptors (abst-2010) http://gut.bmj.com/cgi/content/meeting_abstract/59/1_MeetingAbstracts/A45-a?sid=0731f0e5-2071-4549-be57-57f444307138
Protective effects of the synthetic cannabinoids CP55,940 and JWH-015 on rat brain mito-chondria upon paraquat exposure (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20514518
top
Dopamine modulation of excitatory currents in the striatum is dictated by the expression of D1 or D2 receptors and modified by endocannabinoids (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20092552
Cannabidiol Reduces Aβ-Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARγ Involvement (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3230631/?tool=pubmed
A synaptogenic amide N-docosahexaenoylethanolamide promotes hippocampal development (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3215906/
A catalytically silent FAAH-1 variant drives anandamide transport in neurons (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3245783/
Sex difference in cell proliferation in developing rat amygdala mediated by
endocannabinoids has implications for social behavior (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2996668/?tool=pubmed
Dual inhibition of alpha/beta hydrolase domain 6 and fatty acid amide hydrolase
increases endocannabinoid levels in neurons (full–2011) http://www.jbc.org/content/early/2011/06/10/jbc.M110.202853.long
Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249428/
CNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity (full–2011) http://jop.sagepub.com/content/26/1/92.full
Activation of cannabinoid type 2 receptors inhibits HIV-1 envelope glycoprotein gp120-induced synapse loss (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3164336/
Cannabinoid receptor expression in HIV encephalitis and HIV-associated neuro-pathologic comorbidities (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135748/
Cannabinoid receptor-mediated regulation of neuronal activity in the main olfactory bulb (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3397690/
Cannabinoid receptor agonist protects cultured dopaminergic neurons from the death by the proteasomal dysfunction (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3145842/?tool=pubmed
CB2 Cannabinoid Receptors Promote Neural Progenitor Cell Proliferation via mTORC1 Signaling (full–2011) http://www.jbc.org/content/287/2/1198.full
History of cannabis use is not associated with alterations in striatal dopamine D2/D3 receptor availability (full–2011) http://jop.sagepub.com/content/26/1/144.long
HIV-1 infection and alcohol abuse: neurocognitive impairment, mechanisms of neurodegeneration and therapeutic interventions (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3098312/
Cannabinoid Receptor Type 1 Protects Nigrostriatal Dopaminergic Neurons against MPTP Neurotoxicity by Inhibiting Microglial Activation (full–2011) http://www.jimmunol.org/content/187/12/6508.full?sid=c3422dd2-7ad0-42e4-a862-845dc670f7cf
Endocannabinoid 2-arachidonoylglycerol protects neurons against β-amyloid insults (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3052737/pdf/nihms266962.pdf
top
The Dopamine and Cannabinoid Interaction in the Modulation of Emotions and Cognition: Assessing the Role of Cannabinoid CB1 Receptor in Neurons Expressing Dopamine D1 Receptors (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3156975/
Pharmacological activation/inhibition of the cannabinoid system affects alcohol withdrawal-induced neuronal hypersensitivity to excitotoxic insults (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3158793/
Endocannabinoid signaling in the amygdala: anatomy, synaptic signaling, behavior, and adaptations to stress (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236282/
The major central endocannabinoid directly acts at GABA(A) receptors (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3207709/
N-Docosahhexanoyllethanolamide promotes development of hippocampal neurons (full–2011) http://www.biochemj.org/content/435/2/327
Alterations in Corticolimbic Dendritic Morphology and Emotional Behavior in Cannabinoid CB1 Receptor–Deficient Mice Parallel the Effects of Chronic Stress (full–2011) http://cercor.oxfordjournals.org/content/21/9/2056.full
Synaptic plasticity: A new partnership (article–2011) http://www.lipidmaps.org/update/2011/110201/full/nrn2972.html?s=cannabinoid
History of cannabis use is not associated with alterations in striatal dopamine D2/D3 receptor availability (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21890594
The Effect of Hypoxia on G Protein Coupled (CB1) Receptor Gene Expression in Cortical B50 Neurons in Culture (abst–2011) http://www.maxwellsci.com/jp/abstract.php?jid=BJPT&no=92&abs=05
The G protein-coupled cannabinoid-1 (CB(1)) receptor of mammalian brain: Inhibition by phthalate esters in vitro (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21763743
α-Tocopherol and α-tocopheryl phosphate interact with the cannabinoid system in the rodent hippocampus (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21843633
Plasticity in vagal afferent neurones during feeding and fasting: mechanisms and significance (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21062423
Effects of synthetic cannabinoids on electroencephalogram power spectra in rats (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/21640532/abstract/Effects_of_synthetic_cannabinoids_on_electroencephalogram_power_spectra_in_rats_
Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21278728
Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions. Figure 1: n-3/n-6 PUFA dietary imbalance alters PUFAs level in mouse brain (charts–2011) http://www.nature.com/neuro/journal/v14/n3/fig_tab/nn.2736_F1.html
Δ(9)-THC and WIN55,212-2 affect brain tissue levels of excitatory amino acids in a phenotype-, compound-, dose-, and region-specific manner (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/21645556/abstract/%CE%94_9__THC_and_WIN55212_2_affect_brain_tissue_levels_of_excitatory_amino_acids_in_a_phenotype__compound__dose__and_region_specific_manner_
Palmitoylethanolamide restores myelinated-fibre function in patients with chemotherapy induced painful neuropathy (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22229320
Effects of palmitoylethanolamide on release of mast cell peptidases and neurotrophic factors after spinal cord injury (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21354467
top
EFFECT OF CANNABIS SATIVA ALCOHOLIC EXTRACT ON HIPPOCAMPUS NEURONAL DENSITY IN RATS (abst–2011) http://en.journals.sid.ir/ViewPaper.aspx?ID=258946
EFFECT OF AQUATIC EXTRACT OFCANNABIS SATIVA LEAVES ON DEGENERATION OF ALPHA MOTONEURONS IN SPINAL CORD AFTER SCIATIC NERVE COMPRESSION IN RATS (abst–2011) http://en.journals.sid.ir/ViewPaper.aspx?ID=258699
Increased vulnerability to 6-hydroxydopamine lesion and reduced development of dyskinesias in mice lacking CB1 cannabinoid receptors (abst–2011) http://www.neurobiologyofaging.org/article/S0197-4580%2809%2900116-X/abstract
Endocannabinoids in nervous system health and disease: the big picture in a nutshell (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3193.long
Role of CB1 cannabinoid receptors on GABAergic neurons in brain aging (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3131310/?tool=pubmed
Type-1 Cannabinoid Receptor Signaling in Neuronal Development (full–2012) http://content.karger.com/produktedb/produkte.asp?DOI=000339075&typ=pdf
Cortisol-mediated adhesion of synovial fibroblasts is dependent on the degradation of anandamide and activation of the endocannabinoid system (full-2012) http://onlinelibrary.wiley.com/doi/10.1002/art.37684/pdf
Synaptic Targets of Δ9-Tetrahydrocannabinol in the Central Nervous System (full–2012) http://perspectivesinmedicine.cshlp.org/content/early/2012/12/03/cshperspect.a012237.long
Endocannabinoids and the processing of value-related signals (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3270484/?tool=pubmed
Neuron to Astrocyte Communication via Cannabinoid Receptors Is Necessary for Sustained Epileptiform Activity in Rat Hippocampus (full–2012) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0037320
Pathological plasticity in fragile X syndrome (full–2012) http://www.hindawi.com/journals/np/2012/275630/
Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-α (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3315437/?tool=pubmed
Review article: The endocannabinoid system in normal and pathological brain ageing (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3326.full?sid=161e7b36-5055-448b-962e-697c782e901d
Excitability of prefrontal cortical pyramidal neurons is modulated by activation of 98 intracellular type-2 cannabinoid receptors (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3295302/
Intrinsic Up-Regulation of 2-AG Favors an Area Specific Neuronal Survival in Different In Vitro Models of Neuronal Damage (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3527460/
Functional diversity on synaptic plasticity mediated by endocannabinoids (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3481528/
top
Endocannabinoids via CB₁ receptors act as neurogenic niche cues during cortical development (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3229.long
The CB(2)-preferring agonist JWH015 also potently and efficaciously activates CB(1) in autaptic hippocampal neurons (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601544/
Long-lasting potentiation of hippocampal synaptic transmission by direct cortical input is mediated via endocannabinoids (full–2012) http://jp.physoc.org/content/590/10/2305.full
The CB1 Cannabinoid Receptor Drives Corticospinal Motor Neuron Differentiation through the Ctip2/Satb2 Transcriptional Regulation Axis (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3545190/
Multiple functions of endocannabinoid signaling in the brain (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4273654/
Psychopharmacology of the endocannabinoids: far beyond anandamide (full–2012) http://www.researchgate.net/publication/51201177_Psychopharmacology_of_the_endocannabinoids_far_beyond_anandamide
Endocannabinoid-Goα signalling inhibits axon regeneration in Caenorhabditis elegans by antagonizing Gqα-PKC-JNK signalling (full–2012) http://www.nature.com/ncomms/journal/v3/n10/full/ncomms2136.html
Pharmacological manipulation of cannabinoid neurotransmission reduces neuro-inflammation associated with normal aging (full–2012) http://file.scirp.org/Html/1-8201656_23229.htm
A cell population that strongly expresses the CB1 cannabinoid receptor in the ependyma of the rat spinal cord (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22791629
Mitochondrial CB(1) receptors regulate neuronal energy metabolism (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22388959
Effects of cannabinoids Δ(9)-tetrahydrocannabinol, Δ(9)-tetrahydrocannabinolic acid and cannabidiol in MPP(+) affected murine mesencephalic cultures (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22571976
Cannabinoid modulation of midbrain urocortin 1 neurones during acute and chronic stress (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22734681
Manipulating brain connectivity with δ(9)-tetrahydrocannabinol: A pharmacological resting state FMRI study (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22885247
Cannabinoid CB(1) receptor in the modulation of stress coping behaviour in mice: the role of serotonin and different forebrain neuronal subpopulations (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23000076
The role of endocannabinoids in pain modulation (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/fcp.12008/pdf
Type-1 (CB(1)) Cannabinoid Receptor Promotes Neuronal Differentiation and Maturation of Neural Stem Cells (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0054271
Orexin neurons use endocannabinoids to break obesity-induced inhibition (full–2013) http://www.pnas.org/content/110/24/9625.full
Signaling Pathways Involved in Striatal Synaptic Plasticity are Sensitive to Temporal Pattern and Exhibit Spatial Specificity (full–2013) http://www.ploscompbiol.org/article/info%3Adoi%2F10.1371%2Fjournal.pcbi.1002953
A biophysical model of endocannabinoid-mediated short term depression in hippocampal inhibition (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0058926
top
The endocannabinoid system, cannabinoids, and pain (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820295/
Activation of Type 1 Cannabinoid Receptor (CB1R) Promotes Neurogenesis in Murine
Subventricular Zone Cell Cultures (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0063529
N-arachidonoyl-L-serine (AraS) possesses proneurogenic properties in vitro and in vivo after traumatic brain injury (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3734775/
Using the endocannabinoid system as a neuroprotective strategy in perinatal hypoxic-ischemic brain injury (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4146074/
HINT1 protein cooperates with cannabinoid 1 receptor to negatively regulate glutamate NMDA receptor activity (full–2013) http://www.molecularbrain.com/content/6/1/42
Obesity-driven synaptic remodeling affects endocannabinoid control of orexinergic neurons (full–2013) http://www.pnas.org/content/110/24/E2229.full
Cannabinoid- and lysophosphatidylinositol-sensitive receptor GPR55 boosts neuro-transmitter release at central synapses (full–2013) http://www.pnas.org/content/early/2013/03/06/1211204110.full.pdf+html
Stimulatory and Inhibitory Roles of Brain 2-Arachidonoylglycerol in Bombesin-Induced Central Activation of Adrenomedullary Outflow in Rats (full–2013) https://www.jstage.jst.go.jp/article/jphs/121/2/121_12208FP/_pdf
Association between a genetic variant of type-1 cannabinoid receptor and inflammatory neurodegeneration in multiple sclerosis (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877004/
Relationships between dietary macronutrients and adult neurogenesis in the regulation of energy metabolism (full-2013) http://journals.cambridge.org/action/displayFulltext?type=6&fid=8904779&jid=BJN&volumeId=109&issueId=09&aid=8904778&bodyId=&membershipNumber=&societyETOCSession=&fulltextT ype=RV&fileId=S000711451200579X
Food for thought: hormonal, experiential, and neural influences on feeding and obesity  (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3818543/
Temporal changes of CB1 cannabinoid receptor in the basal ganglia as a possible structure-specific plasticity process in 6-OHDA lesioned rats (full–2013) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0076874
Neuroprotective effects of Cannabis sativa leaves extracts on α-Motoneurons density after sciatic nerve injury in rats (full–2013) http://www.lifesciencesite.com/lsj/life1005s/113_15973life1005s_644_648.pdf
Neuron-type specific cannabinoid-mediated G protein signalling in mouse hippocampus (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/jnc.12137/full
Diacylglycerol Lipaseα (DAGLα) and DAGLβ Cooperatively Regulate the Production of 2-Arachidonoyl Glycerol in Autaptic Hippocampal Neurons (full–2013) http://molpharm.aspetjournals.org/content/84/2/296.full.pdf+html
CB2 Receptor Agonists Protect Human Dopaminergic Neurons against Damage from HIV-1 gp120 (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0077577
top
Astroglial CB1 cannabinoid receptors regulate leptin signaling in mouse brain astrocytes (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3854987/
Sex-specific tonic 2-arachidonoylglycerol signaling at inhibitory inputs onto dopamine neurons of Lister Hooded rats (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3867690/
Insulin induces long-term depression of VTA dopamine neurons via endocannabinoids (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072656/
Rapid Glucocorticoid-Induced Activation of TRP and CB1 Receptors Causes Biphasic Modulation of Glutamate Release in Gastric-Related Hypothalamic Preautonomic Neurons (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3560102/
Activation-dependent plasticity of polarized GPCR distribution on the neuronal surface (full–2013) http://jmcb.oxfordjournals.org/content/5/4/250.long
Therapeutic Opportunities through the Modulation of Endocannabinoid Transport (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4255948/
CB2 cannabinoid agonist enhanced neurogenesis in GFAP/Gp120 transgenic mice displaying deficits in neurogenesis (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3904265/
CB1 Cannabinoid Receptors Promote Maximal FAK Catalytic Activity By Stimulating Cooperative Signaling Between Receptor Tyrosine Kinases and Integrins in Neuronal Cells (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165595/
Acute inhibition of diacylglycerol lipase blocks endocannabinoid-mediated retrograde synaptic suppression: evidence for on-demand biosynthesis of 2-arachidonoylglycerol (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3800453/
Optogenetic identification of an intrinsic cholinergically driven inhibitory oscillator sensitive to cannabinoids and opioids in hippocampal CA1 (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3903354/
Induction of Endocannabinoid Levels in Juvenile Rat Brain Following Developmental Chlorpyrifos Exposure (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3954109/
High fat diet and body weight have different effects on cannabinoid CB1 receptor expression in rat nodose ganglia (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3866822/
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies (full–2013) http://www.karger.com/Article/FullText/350094
The role of endocannabinoids in pain modulation (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23278562
The neuroprotective role of endocannabinoids against chemical-induced injury and other adverse effects (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23296873
2-AG into the lateral hypothalamus increases REM sleep and cFos expression in melanin concentrating hormone neurons in rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23603032
The satiety signal oleoylethanolamide stimulates oxytocin neurosecretion from rat hypothalamic neurons (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23959001
top
Anandamide produced by Ca2+-insensitive enzymes induces excitation in primary sensory neurons (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24114173
Cytotoxicity of synthetic cannabinoids on primary neuronal cells of the forebrain: the involvement of cannabinoid CB1 receptors and apoptotic cell death (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24211273
Glutamate spillover drives endocannabinoid production and inhibits GABAergic transmission in the Substantia Nigra pars compacta (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24334069
Motor effects of the non-psychotropic phytocannabinoid cannabidiol that are mediated by 5-HT1A receptors (abst–2013) http://www.sciencedirect.com/science/article/pii/S0028390813003419
Δ(9)-THC and N-arachidonoyl glycine regulate BV-2 microglial morphology and cytokine release plasticity: implications for signaling at GPR18 (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877838/
Presynaptic mechanisms of neuronal plasticity and their role in epilepsy (full–2014) http://journal.frontiersin.org/Journal/10.3389/fncel.2014.00164/full
Endogenous Signaling by Omega-3 Docosahexaenoic Acid-derived Mediators Sustains Homeostatic Synaptic and Circuitry Integrity (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180614/
Cannabinoid, melanocortin and opioid receptor expression on DRD1 and DRD2 sub-populations in rat striatum (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3972466/
Anandamide Protects HT22 Cells Exposed to Hydrogen Peroxide by Inhibiting CB1 Receptor-Mediated Type 2 NADPH Oxidase (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4127243/
Regulatory effects of anandamide on intracellular Ca(2+) concentration increase in trigeminal ganglion neurons (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4146256/
Endocannabinoid-dependent modulation of phasic dopamine signaling encodes external and internal reward-predictive cues (full–2014) http://journal.frontiersin.org/Journal/10.3389/fpsyt.2014.00118/full
Cannabinoid receptors contribute to astroglial Ca2+-signalling and control of synaptic plasticity in the neocortex (full–2014) http://rstb.royalsocietypublishing.org/content/369/1654/20140077.long
Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice (full–2014) http://www.pnas.org/content/early/2014/10/30/1413210111.long
High hopes for CB(2) receptors in neurogenesis (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/bph.12548/full
Input- and Cell-Type-Specific Endocannabinoid-Dependent LTD in the Striatum (full–2014) http://www.cell.com/cell-reports/fulltext/S2211-1247%2814%2901016-X
Individual differences in response to positive and negative stimuli: endocannabinoidbased insight on approach and avoidance behaviors (full–2014) http://journal.frontiersin.org/Journal/10.3389/fnsys.2014.00238/full
CB1 cannabinoid receptor in SF1-expressing neurons of the ventromedial hypothalamus determines metabolic responses to diet and leptin (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4209357/
top
CB1 augments mGluR5 function in medial prefrontal cortical neurons to inhibit amygdala hyperactivity in an arthritis pain model (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288820/
β-Amyloid Inhibits E-S Potentiation through Suppression of Cannabinoid Receptor 1-Dependent Synaptic Disinhibition (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4114400/
Control of Inhibition by the Direct Action of Cannabinoids on GABAA Receptors (full–2014) http://cercor.oxfordjournals.org/content/early/2014/03/18/cercor.bhu045.long
Δ(9)-THC and N-arachidonoyl glycine regulate BV-2 microglial morphology and cytokine release plasticity: implications for signaling at GPR18 (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877838/
The cannabinoid CB2 receptor agonist AM1241 enhances neurogenesis in GFAP / Gp120 transgenic mice displaying deficits in neurogenesis (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/bph.12478/full
Fatty Acid-binding Protein 5 (FABP5) Regulates Cognitive Function Both by Decreasing Anandamide Levels and by Activating the Nuclear Receptor Peroxisome Proliferatoractivated Receptor β/δ (PPARβ/δ) in the Brain (full–2014) http://www.jbc.org/content/289/18/12748.full.pdf+html
Multiple Mechanistically Distinct Modes of Endocannabinoid Mobilization at Central Amygdala Glutamatergic Synapses (full–2014) http://www.sciencedirect.com/science/article/pii/S0896627314000178
Advances in the management of multiple sclerosis spasticity: multiple sclerosis spasticity nervous pathways (full–2014) http://www.karger.com/Article/Pdf/367615
Control of synaptic function by endocannabinoid-mediated retrograde signaling (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237895/
Effects of pubertal cannabinoid administration on attentional set-shifting and dopaminergic hyper-responsivity in a developmental disruption model of schizophrenia (full–2014) http://ijnp.oxfordjournals.org/content/ijnp/18/2/pyu018.full.pdf
Hypoximimetic activity of N-acyl-dopamines. N-arachidonoyl-dopamine stabilizes HIF-1α protein through a SIAH2-dependent pathway (full–2014) http://www.sciencedirect.com/science/article/pii/S0167488914002821
Astrocytes in endocannabinoid signalling (full–2014) http://rstb.royalsocietypublishing.org/content/369/1654/20130599
Systemic Administration of Oleoylethanolamide Protects from Neuroinflammation and Anhedonia Induced by LPS in Rats (full–2014) http://ijnp.oxfordjournals.org/content/18/6/pyu111
Cannabinoid Receptor Type 2 Agonist Attenuates Apoptosis by Activation of Phosphorylated CREB-Bcl-2 Pathway After Subarachnoid Hemorrhage in Rats (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4194247/
Molecular Basis for the Improvement in Muscle Metaboreflex and Mechanoreflex Control in Exercise-Trained Humans with Chronic Heart Failure (full–2014) http://ajpheart.physiology.org/content/307/11/H1655
Role of corticosterone in the murine enteric nervous system during fasting (full–2014) http://ajpgi.physiology.org/content/307/9/G905
top
Impaired Neurogenesis by HIV-1-Gp120 is Rescued by genetic deletion of Fatty Acid Amide Hydrolase Enzyme (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4594266/
Genetic rescue of CB1 receptors on medium spiny neurons prevents loss of excitatory striatal synapses but not motor impairment in HD mice (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4180675/
Morphological and Behavioural Evidence for Impaired Prefrontal Cortical Function in Female CB1 Receptor Deficient Mice (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4128323/
Endocannabinoid modulation by FAAH and MAGL within the analgesic circuitry of the periaqueductal grey (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4294036/
Activation of CB1 inhibits NGF-induced sensitization of TRPV1 in adult mouse afferent neurons (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4626020/
Developmental Increase in Hippocampal Endocannabinoid Mobilization: Role of Metabotropic Glutamate Receptor Subtype 5 and Phospholipase C (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233278/
Type 1 Cannabinoid Receptor Ligands Display Functional Selectivity in a Cell Culture Model of Striatal Medium Spiny Projection Neurons (full–2014) http://www.jbc.org/content/289/36/24845.long
Hippocampal Cannabinoid Transmission Modulates Dopamine Neuron Activity: Impact on Rewarding Memory Formation and Social Interaction (full–2014) http://www.nature.com/npp/journal/v40/n6/full/npp2014329a.html
Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4765324/
Normal aging in rats and pathological aging in human Alzheimer disease decrease FAAH activity: Modulation by cannabinoid agonists (full–2014) http://www.sciencedirect.com/science/article/pii/S0531556514002903
Cannabinoid Type 1 (CB1) Receptors on Sim1-Expressing Neurons Regulate Energy Expenditure in Male Mice (full–2014) http://press.endocrine.org/doi/10.1210/en.2014-1437
Prior stimulation of the endocannabinoid system prevents methamphetamine-induced dopaminergic neurotoxicity in the striatum through activation of CB2 receptors (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939842/
Multifractal analysis of information processing in hippocampal neural ensembles during working memory under Δ9-tetrahydrocannabinol administration (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4312266/
Endocannabinoids in Synaptic Plasticity and Neuroprotection (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4143501/
Chronic activation of CB2 cannabinoid receptors in the hippocampus increases excitatory synaptic transmission (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4398527/
Cannabinoid modulation of drug reward and the implications of marijuana legalization (full–2014) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4442758/
The Neurobiology of Cancer Pain (full–2014) http://journals.sagepub.com/doi/full/10.1177/1073858414525828
Effects of cannabidiol in the treatment of patients with Parkinson’s disease: An exploratory double-blind trial (full–2014) http://journals.sagepub.com/doi/full/10.1177/0269881114550355
Programming and reprogramming neural cells by (endo-) cannabinoids: from physiological rules to emerging therapies (full–2014) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4765324/
Nutritional omega-3 modulates neuronal morphology in the prefrontal cortex along with depression-related behaviour through corticosterone secretion (full–2014) http://www.nature.com/tp/journal/v4/n9/full/tp201477a.html
Anandamide in primary sensory neurons: too much of a good thing? (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24494681
Trans-Caryophyllene Suppresses Hypoxia-Induced Neuroinflammatory Responses by Inhibiting NF-κB Activation in Microglia (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24488604
Endocannabinoid 2-Arachidonylglycerol Protects Primary Cultured Neurons Against LPS-Induced Impairments in Rat Caudate Nucleus (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24510751
Cellular approaches to the interaction between cannabinoid receptor ligands and nicotinic acetylcholine receptors (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24642359
Mechanisms of synaptic dysfunction and excitotoxicity in Huntington’s disease (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24603212
Endocannabinoid-mediated retrograde modulation of synaptic transmission (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24747340
Inhibition of Peripheral Fatty Acid Amide Hydrolase Depresses Activities of Bladder Mechanosensitive Nerve Fibers of the Rat (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24746881
Effect of N-Arachidonoyl Dopamine on Activity of Neuronal Network in Primary Hippo-campus Culture upon Hypoxia Modelling (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24771427
Roles of fatty acid ethanolamides (FAE) in traumatic and ischemic brain injury (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24874648
Endocannabinoid signaling modulates neurons of the pedunculopontine nucleus (PPN) via astrocytes (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25009314
Cannabinoid Receptor-2 and HIV-Associated Neurocognitive Disorders (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25015040
Cannabinoid receptor intracellular signalling: The long journey from binding sites to biological effects (abst–2014) http://onlinelibrary.wiley.com/doi/10.1002/9781118451281.ch2/summary
The Neurobiology of Cancer Pain (abst–2014) http://nro.sagepub.com/content/early/2014/03/24/1073858414525828.abstract
The interaction between serotonergic and cannabinoidergic modulations involved in the fear extinction (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25069241
Descending modulation of pain: the GABA disinhibition hypothesis of analgesia (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25064178
Chronic cannabinoid receptor stimulation selectively prevents motor impairments in a mouse model of Huntington’s disease (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25123645
Analysis in conditional cannabinoid 1 receptor-knockout mice reveals neuronal sub-population-specific effects on epileptogenesis in the kindling paradigm (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25123336
Cannabinoid-mediated short-term plasticity in hippocampus (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25123173
Differential regulation of NMDAR and NMDAR-mediated metaplasticity by anandamide and 2-AG in the hippocampus (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25087967
Cannabinoid-induced changes in respiration of brain mitochondria (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25195527
Inhibition of endocannabinoid neuronal uptake and hydrolysis as strategies for developing anxiolytic drugs (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25083569
Differences in receptor binding affinity of several phytocannabinoids does not explain their effects on neural cell cultures (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25311884
Post-status epilepticus treatment with the cannabinoid agonist WIN 55,212-2 prevents chronic epileptic hippocampal damage in rats (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25447228
Cannabinoid receptor agonists reduce the short-term mitochondrial dysfunction and oxidative stress linked to excitotoxicity in the rat brain (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25446347
Identification of CB2 receptors in human nigral neurons that degenerate in Parkinson’s disease (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25481767
Cerebellar Endocannabinoids: Retrograde Signaling from Purkinje Cells (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25520276
Protective effects of cannabidiol against hippocampal cell death and cognitive impairment induced by bilateral common carotid artery occlusion in mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24532152
Magnolol protects neurons against ischemia injury via the downregulation of p38/MAPK, CHOP and nitrotyrosine (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25038313
Endocannabinoid Modulation of Synaptic Inputs to Magnocellular Neurons (abst-2014) http://onlinelibrary.wiley.com/doi/10.1002/9781118606803.ch10/summary
Nonpsychotropic Plant Cannabinoids, Cannabidivarin (CBDV) and Cannabidiol (CBD), Activate and Desensitize Transient Receptor Potential Vanilloid 1 (TRPV1) Channels in Vitro: Potential for the Treatment of Neuronal Hyperexcitability (abst–2014) http://pubs.acs.org/doi/abs/10.1021/cn5000524
Augmented Inhibition from Cannabinoid-Sensitive Interneurons Diminishes CA1 Output after Traumatic Brain Injury (full–2015) http://journal.frontiersin.org/Journal/10.3389/fncel.2014.00435/full
top
Blockade of monoacylglycerol lipase inhibits oligodendrocyte excitotoxicity and prevents demyelination in vivo (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/glia.22742/full
Cocaine-induced endocannabinoid release modulates behavioral and neurochemical sensitization in mice (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/adb.12080/full
Cannabinoid receptor 1 signaling in cardiovascular regulating nuclei in the brainstem: A review (full–2015) http://www.ncbi.nlm.nih.gov/pubmed/25685481
Genetic Dissection of Behavioural and Autonomic Effects of Δ9-Tetrahydrocannabinol in Mice (full–2015) http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.0050269
top
The Combined Inhibitory Effect of the Adenosine A1 and Cannabinoid CB1 Receptors on cAMP Accumulation in the Hippocampus Is Additive and Independent of A1 Receptor Desensitization (full–2015) http://www.hindawi.com/journals/bmri/2015/872684/
Drugs of Abuse in HIV infection and neurotoxicity (full–2015) http://journal.frontiersin.org/article/10.3389/fmicb.2015.00217/full
Negative Regulation of Leptin-induced ROS Formation by CB1 Receptor Activation in Hypothalamic Neurons (full–2015) http://www.jbc.org/content/early/2015/04/13/jbc.M115.646885.full.pdf+html
WIN 55,212-2, Agonist of Cannabinoid Receptors, Prevents Amyloid β1-42 Effects on Astrocytes in Primary Culture (full–2015) http://www.plosone.org/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0122843&representation=PDF
Exposure to Allergen Causes Changes in NTS Neural Activities after Intratracheal Capsaicin Application, in Endocannabinoid Levels and in the Glia Morphology of NTS (full–2015) http://www.hindawi.com/journals/bmri/2015/980983/
Promising cannabinoid-based therapies for Parkinson’s disease: motor symptoms to neuroprotection (full–2015) http://www.molecularneurodegeneration.com/content/pdf/s13024-015-0012-0.pdf
Role for Endogenous BDNF in Endocannabinoid-Mediated Long-Term Depression at Neocortical Inhibitory Synapses (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415885/
Sex-dependent vulnerability to Cannabis abuse in adolescence (full–2015) http://journal.frontiersin.org/article/10.3389/fpsyt.2015.00056/full
Involvement of GluR2 up-regulation in neuroprotection by electroacupuncture pretreatment via cannabinoid CB1 receptor in mice (full–2015) http://www.nature.com/srep/2015/150330/srep09490/full/srep09490.html
Effects of high-fructose diets on central appetite signaling and cognitive function (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429636/
Rapid Non-Genomic Glucocorticoid Actions in Male Mouse Hypothalamic Neuroendocrine Cells Are Dependent on the Nuclear Glucocorticoid Receptor (full–2015) http://press.endocrine.org/doi/pdf/10.1210/en.2015-1273
The CB1 cannabinoid receptor signals striatal neuroprotection via a PI3K / Akt / mTORC1 / BDNF pathway (full–2015) http://www.nature.com/cdd/journal/vaop/ncurrent/full/cdd201511a.html
Cannabinoid CB2 Receptors in a Mouse Model of Aβ Amyloidosis: Immunohistochemical Analysis and Suitability as a PET Biomarker of Neuroinflammation (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0129618
Palmitoylethanolamide Inhibits Glutamate Release in Rat Cerebrocortical Nerve Terminals (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4394492/
Tonic endocannabinoid-mediated modulation of GABA release is independent of the CB1 content of axon terminals (full–2015) http://www.nature.com/ncomms/2015/150420/ncomms7557/full/ncomms7557.html
Anandamide, Acting via CB2 Receptors, Alleviates LPS-Induced Neuroinflammation in Rat Primary Microglial Cultures (full–2015) http://www.hindawi.com/journals/np/2015/130639/
Hypothalamic POMC neurons promote cannabinoid-induced feeding (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496586/
Homeostatic regulation of brain functions by endocannabinoid signaling (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468750/
top
Metabolic Interplay between Astrocytes and Neurons Regulates Endocannabinoid Action (full–2015) http://www.cell.com/cell-reports/fulltext/S2211-1247%2815%2900725-1
Impaired 2-AG signaling in hippocampal glutamatergic neurons: aggravation of anxietylike behavior and unaltered seizure susceptibility (full–2015) http://ijnp.oxfordjournals.org/content/ijnp/early/2015/07/29/ijnp.pyv091.full.pdf
Multiple Forms of Endocannabinoid and Endovanilloid Signaling Regulate the Tonic Control of GABA Release (full–2015) http://www.jneurosci.org/content/35/27/10039.full?sid=7e769d1b-9b77-42fe-92d0-8b337b34b9b6
Endogenous vs Exogenous Allosteric Modulators in GPCRs: A dispute for shuttling CB1 among different membrane microenvironments (full–2015) http://www.nature.com/articles/srep15453
Pharmacological activation of CB2 receptors counteracts the deleterious effect of ethanol on cell proliferation in the main neurogenic zones of the adult rat brain (full–2015) http://journal.frontiersin.org/article/10.3389/fncel.2015.00379/full
The Cannabinoid Receptor CB1 Interacts with the WAVE1 Complex and Plays a Role in Actin Dynamics and Structural Plasticity in Neurons (full–2015) http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.1002286
Increased Cortical Inhibition in Autism-Linked Neuroligin-3R451C Mice Is Due in Part to Loss of Endocannabinoid Signaling (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0140638
Coordinated Regulation of Synaptic Plasticity at Striatopallidal and Striatonigral Neurons Orchestrates Motor Control (full–2015) http://www.cell.com/cell-reports/fulltext/S2211-1247%2815%2901163-8
Fine-tuning of synaptic upscaling at excitatory synapses by endocannabinoid signaling is mediated via the CB1 receptor (full–2015) http://www.nature.com/articles/srep16257
Fetal Alcohol Spectrum Disorder: Potential Role of Endocannabinoids Signaling (full–2015) http://www.mdpi.com/2076-3425/5/4/456/htm
Endocannabinoid signaling mediates oxytocin-driven social reward (full–2015) http://www.pnas.org/content/112/45/14084.full
Ventral tegmental area dopamine and GABA neurons: Physiological properties and expression of mRNA for endocannabinoid biosynthetic elements (full–2015) http://www.nature.com/articles/srep16176
Loss of Either Rac1 or Rac3 GTPase Differentially Affects the Behavior of Mutant Mice and the Development of Functional GABAergic Networks (full–2015) http://cercor.oxfordjournals.org/content/early/2015/11/17/cercor.bhv274.long
Hypothalamic control of brown adipose tissue thermogenesis (full–2015) http://journal.frontiersin.org/article/10.3389/fnsys.2015.00150/full
CB1 cannabinoid receptor enrichment in the ependymal region of the adult human spinal cord (full–2015) http://www.nature.com/articles/srep17745
Loss of Either Rac1 or Rac3 GTPase Differentially Affects the Behavior of Mutant Mice and the Development of Functional GABAergic Networks (full–2015) http://cercor.oxfordjournals.org/content/early/2015/11/17/cercor.bhv274.long Hypothalamic control of brown adipose tissue thermogenesis (full–2015) http://journal.frontiersin.org/article/10.3389/fnsys.2015.00150/full
CB1 cannabinoid receptor enrichment in the ependymal region of the adult human spinal cord (full–2015) http://www.nature.com/articles/srep17745
Endocannabinoids Mediate Muscarinic Acetylcholine Receptor-Dependent Long-Term Depression in the Adult Medial Prefrontal Cortex (full–2015) http://journal.frontiersin.org/article/10.3389/fncel.2015.00457/full
Cannabinoid receptor activation in the juvenile rat brain results in rapid biomechanical alterations: Neurovascular mechanism as a putative confounding factor (full–2015) http://jcb.sagepub.com/content/early/2015/09/23/0271678X15606923.long
top
cnrip1 is a regulator of eye and neural development in Xenopus laevis (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/gtc.12225/full
To Act or Not to Act: Endocannabinoid/Dopamine Interactions in Decision-Making (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4681836/
Neural correlates of cannabidiol and Δ9-tetrahydrocannabinol interactions in mice: implications for medical cannabis (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/bph.13333/full
Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease (full–2015) http://www.sciencedirect.com/science/article/pii/S0014488615300583
Deletion of Monoglyceride Lipase in Astrocytes Attenuates Lipopolysaccharide-Induced Neuroinflammation (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705409/
Cocaine-Induced Endocannabinoid Mobilization in the Ventral Tegmental Area (full–2015) http://www.cell.com/cell-reports/fulltext/S2211-1247%2815%2900926-2
Cellular Mechanisms of Action of Drug Abuse on Olfactory Neurons (full–2015) http://www.mdpi.com/1660-4601/13/1/5/htm
Interactions between ethanol and the endocannabinoid system at GABAergic synapses on basolateral amygdala principal neurons (full–2015) http://www.alcoholjournal.org/article/S0741-8329%2815%2930019-7/fulltext
Corticotropin-Releasing Hormone Drives Anandamide Hydrolysis in the Amygdala to Promote Anxiety (full-2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348185/
Mitochondrial CB1 receptor is involved in ACEA-induced protective effects on neurons and mitochondrial functions (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516969/
VGluT3-Expressing CCK-Positive Basket Cells Construct Invaginating Synapses Enriched with Endocannabinoid Signaling Proteins in Particular Cortical and Cortex-Like Amygdaloid Regions of Mouse Brains (full–2015) http://www.jneurosci.org/content/35/10/4215.long
Cannabinoid CB1 Receptor Calibrates Excitatory Synaptic Balance in the Mouse Hippocampus (full–2015) http://www.jneurosci.org/content/35/9/3842.long
Role of dopamine type 1 receptors and DARPP-32 in Δ9-THC-mediated induction of ΔFosB in the mouse forebrain (full–2015) http://jpet.aspetjournals.org/content/early/2015/06/22/jpet.115.224428.long
Neurotoxicity of Synthetic Cannabinoids JWH-081 and JWH-210 (full–2015) http://www.biomolther.org/journal/view.html?volume=23&number=6&spage=597&year=2015
The basolateral amygdala γ-aminobutyric acidergic system in health and disease (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/jnr.23690/full
Endocannabinoid Signaling in Motivation, Reward, and Addiction: Influences on Mesocorticolimbic Dopamine Function (full–2015) http://www.sciencedirect.com/science/article/pii/S007477421500135X
Acute and Chronic Ethanol Exposure Differentially Regulate CB1 Receptor Function at Glutamatergic Synapses in the Rat Basolateral Amygdala (full–2015) http://www.sciencedirect.com/science/article/pii/S002839081530201X
Postnatal ethanol exposure alters levels of 2-arachidonylglycerol-metabolizing enzymes and pharmacological inhibition of monoacylglycerol (MAGL) does not cause neurodegeneration in neonatal mice (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490952/
Enhancement of endocannabinoid signalling protects against cocaine-induced neurotoxicity (full–2015) http://www.sciencedirect.com/science/article/pii/S0041008X15001556
Cannabinoid-dopamine interactions in the physiology and physiopathology of the basal ganglia (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/bph.13215/full
Opposite control of frontocortical 2-arachidonoylglycerol turnover rate by cannabinoid type-1 (CB1 ) receptors located on glutamatergic neurons and on astrocytes (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/jnc.13044/full
Simultaneous inhibition of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL) shares discriminative stimulus effects with ∆9-THC in mice (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407717/
Peroxide-Dependent MGL Sulfenylation Regulates 2-AG-Mediated Endocannabinoid Signaling in Brain Neurons (full–2015) http://www.sciencedirect.com/science/article/pii/S107455211500157X
A highly selective, reversible inhibitor identified by comparative chemoproteomics modulates diacylglycerol lipase activity in neurons (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773911/
Anandamide Depresses Glycinergic and GABAergic Inhibitory Transmissions in Adult Rat Substantia Gelatinosa Neurons (full–2015) http://file.scirp.org/Html/1-2500613_54452.htm
Cannabinoid receptor interacting protein (CRIP1a) attenuates CB1R signaling in neuronal cells (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4332989/
Cannabinoid Receptor–Interacting Protein 1a Modulates CB1 Receptor Signaling and Regulation (full–2015) http://molpharm.aspetjournals.org/content/87/4/747.long
Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604192/
Neuronal expression of CB2 cannabinoid receptor mRNAs in the mouse hippocampus (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4917208/
The role of cannabinoids in adult neurogenesis (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4543605/
Differential Pharmacological Regulation of Sensorimotor-Gating Deficit in CB1 Knockout Mice and Associated Neurochemical and Histological Alterations (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4569956/
An endocannabinoid system is present in the mouse olfactory epithelium but does not modulate olfaction (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485596/
Ultrastructural evidence for synaptic contacts between cortical noradrenergic afferents and endocannabinoid-synthesizing post-synaptic neurons (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4542008/
Cannabinoid receptor type 1 agonist ACEA improves motor recovery and protects neurons in ischemic stroke in mice (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/jnc.13288/full
Habenular CB1 Receptors Control the Expression of Aversive Memories (full – 2015) http://www.cell.com/neuron/fulltext/S0896-6273(15)00729-1
β-Neurexins Control Neural Circuits by Regulating Synaptic Endocannabinoid Signaling (full–2015) http://www.cell.com/cell/fulltext/S0092-8674(15)00826-0
Detection of cannabinoid receptors CB1 and CB2 within basal ganglia output neurons in macaques: changes following experimental parkinsonism (link to PDF–2015) http://link.springer.com/article/10.1007/s00429-014-0823-8
top
Dissecting the cannabinergic control of behavior: The where matters (abst–2015) http://onlinelibrary.wiley.com/doi/10.1002/bies.201500046/abstract;jsessionid=222EC084D6C5E7ECF95BFF9D2752CFE4.f01t01
Active endocannabinoids are secreted on extracellular membrane vesicles (abst–2015) http://embor.embopress.org/content/early/2015/01/07/embr.201439668
On the Role of Astroglial Syncytia in Self-Repairing Spiking Neural Networks (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25576582
Cannabinoid agonists rearrange synaptic vesicles at excitatory synapses and depress motoneuron activity in vivo (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25595101
Changes in the endocannabinoid signaling system in CNS structures of TDP-43 transgenic mice: relevance for a neuroprotective therapy in TDP-43-related disorders (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25819934
N-stearoyltyrosine protects primary cortical neurons against Aβ(1-40)-induced injury through inhibiting endocannabinoid degradation (abst–2015) http://www.sciencedirect.com/science/article/pii/S0024320515000521
Opposite control of frontocortical 2-arachidonoylglycerol turnover rate by cannabinoid type-1 (CB1 ) receptors located on glutamatergic neurons and on astrocytes (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25626460
A Synthetic Cannabinoid MAM-2201 Potently Suppresses Synaptic Transmission via
Activation of Presynaptic CB1 Receptors and Reduces Synaptically-Evoked Intracellular Ca2+ Transients in Cerebellar Purkinje Cells (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25747605
Phenotype-dependent inhibition of glutamatergic transmission on nucleus accumbens medium spiny neurons by the abused inhalant toluene (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25752326
Spinal neuronal cannabinoid receptors mediate urodynamic effects of systemic fatty acid amide hydrolase (FAAH) inhibition in rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25788026
N-stearoyltyrosine protects primary cortical neurons against Aβ(1-40)-induced injury through inhibiting endocannabinoid degradation (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25637682
Further Evidence for the Neuroplastic Role of Cannabinoids: A Study in Organotypic Hippocampal Slice Cultures (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25645684
Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 suppress chronic cerebral hypoperfusion-induced neuronal apoptosis by inhibiting c-Jun N-terminal kinase signaling (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25795598
Individual differences and vulnerability to drug addiction: a focus on the endocannabinoid system (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25714966
Analysis of calretinin early expression in the rat hippocampus after beta amyloid (1-42) peptide injection (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25813826
2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25814137
Localization and production of peptide endocannabinoids in the rodent CNS and adrenal medulla (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25839900
The interactive role of cannabinoid and vanilloid systems in hippocampal synaptic plasticity in rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25843413
top
Dissociation between the panicolytic effect of cannabidiol microinjected into the substantia nigra, pars reticulata, and fear-induced antinociception elicited by bicuculline administration in deep layers of the superior colliculus: The role of CB1-endoccannabinoid receptor in the ventral mesencephalon (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25841876
Emerging concepts of pain therapy based on neuronal mechanisms (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25846611
Potential of the cannabinoid CB2 receptor as a pharmacological target against inflammation in Parkinson’s disease (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25863279
Inhibition of FAAH reduces nitroglycerin-induced migraine-like pain and trigeminal neuronal hyperactivity in mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25910421
Enhanced function of inhibitory presynaptic cannabinoid CB1 receptors on sympathetic nerves of DOCA-salt hypertensive rats (abst–2015) http://www.sciencedirect.com/science/article/pii/S0024320515002155
The effect of endocannabinoid system in ischemia-reperfusion injury: a friend or a foe? (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25936364
Chronic ethanol exposure decreases CB1 receptor function at GABAergic synapses in the rat central amygdala (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25940135
Astroglial type-1 cannabinoid receptors (CB1): A new player in the tripartite synapse (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25967266
Layer-specific endocannabinoid-mediated LTD of GABAergic neurotransmission onto principal neurons in mouse visual cortex (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25997857
Involvement of cannabinoid receptors in infrasonic noise-induced neuronal impairment (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26058582
Signaling Mechanism of Cannabinoid Receptor-2 Activation-Induced β-Endorphin Release (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26108183
Colocalization of cannabinoid receptor 1 with somatostatin and neuronal nitric oxide synthase in rat brain hippocampus (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26115586
Endocannabinoid signaling mechanisms in the substantia nigra pars reticulata modulate GABAergic nigrotectal pathways in mice threatened by urutu-cruzeiro venomous pit viper snake (abst–2015) http://www.sciencedirect.com/science/article/pii/S0306452215005898
Effect of Homocysteine on Voltage-Gated Sodium Channel Currents in Primary Cultured Rat Caudate Nucleus Neurons and Its Modulation by 2-Arachidonylglycerol (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26179279
Comparative effects of parathion and chlorpyrifos on endocannabinoid and endocannabinoid-like lipid metabolites in rat striatum (abst–2015)
http://www.ncbi.nlm.nih.gov/pubmed/26215119
ACEA (a highly selective cannabinoid CB1 receptor agonist) stimulates hippocampal neurogenesis in mice treated with antiepileptic drugs (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26225920
Physiological roles for the subfornical organ – A dynamic transcriptome shaped by autonomic state (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26227400
Neuroprotective mechanisms of cannabinoids in brain ischemia and neurodegenerative disorders (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26299059
Pro-inflammatory obesity in aged cannabinoid-2 receptor deficient mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26303348
Genetic Manipulation of the Endocannabinoid System (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26408160
Neuroprotective Effect Is Driven Through the Upregulation of CB1 Receptor in Experimental Autoimmune Encephalomyelitis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26411568
Chronic stress and peripheral pain: Evidence for distinct, region-specific changes in visceral and somatosensory pain regulatory pathways (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26408049
Intracellular postsynaptic cannabinoid receptors link thyrotropin-releasing hormone receptors to TRPC-like channels in thalamic paraventricular nucleus neurons (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26470810
Excitatory drive from the subthalamic nucleus attenuates GABAergic transmission in the Substantia Nigra pars compacta via endocannabinoids (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26472124
Dopamine-dependent CB1 receptor dysfunction at corticostriatal synapses in homozygous PINK1 knockout mice (abst–2015) http://www.sciencedirect.com/science/article/pii/S0028390815301441
The brain in bone and fuel metabolism (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26545334
Maternal separation and early stress cause long-lasting effects on dopaminergic and endocannabinergic systems and alters dendritic morphology in the nucleus accumbens and frontal cortex in rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26539755
top
The neuroprotection of cannabidiol against MPP+-induced toxicity in PC12 cells involves trkA receptors, upregulation of axonal and synaptic proteins, neuritogenesis, and might be relevant to Parkinson’s disease (abst–2015) http://www.sciencedirect.com/science/article/pii/S0887233315300047
The interactive role of CB1 and GABAB receptors in hippocampal synaptic plasticity in rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26611204
The Endocannabinoid System and Its Role in Regulating the Intrinsic Neural Circuitry of the Gastrointestinal Tract (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26638765
Cannabinoid Transmission in the Hippocampus Activates Nucleus Accumbens Neurons and Modulates Reward and Aversion-Related Emotional Salience (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26681496
Signaling Mechanism of Cannabinoid Receptor-2 Activation-Induced β-Endorphin Release (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26108183
Oxytocin Enhances Pleasure of Social Interactions by Stimulating Production of “Bliss Molecule” (news & abstract–2015) http://neurosciencenews.com/oxytocin-anandamide-2926/
Cannabinoid Receptors May Control Aversive Memories (news & abstract-2015) http://neurosciencenews.com/habenula-cb1-receptors-memory-2742/
Expression and Function of the Endocannabinoid System in the Retina and the Visual Brain (full–2016) http://www.hindawi.com/journals/np/2016/9247057/
Characterization of a novel adult murine immortalized microglial cell line and its activation by amyloid-beta (full–2016) http://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0484-z
GABABR-Dependent Long-Term Depression at Hippocampal Synapses between CB1- Positive Interneurons and CA1 Pyramidal Cells (full–2016) http://journal.frontiersin.org/article/10.3389/fncel.2016.00004/full
GABA and Endocannabinoids Mediate Depotentiation of Schaffer Collateral Synapses Induced by Stimulation of Temperoammonic Inputs (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0149034
top
Endogenous and Synthetic Cannabinoids as Therapeutics in Retinal Disease (full–2016) http://www.hindawi.com/journals/np/2016/8373020/
Systematic Review of Pharmacological Properties of the Oligodendrocyte Lineage (full–2016) http://journal.frontiersin.org/article/10.3389/fncel.2016.00027/full
Monoacylglycerol lipase inhibitors produce pro- or antidepressant responses via hippocampal CA1 GABAergic synapses (full–2016) http://www.nature.com/mp/journal/vaop/ncurrent/full/mp201622a.html
Estrogen Receptor Beta and 2-arachidonoylglycerol Mediate the Suppressive Effects of Estradiol on Frequency of Postsynaptic Currents in Gonadotropin-Releasing Hormone Neurons of Metestrous Mice: An Acute Slice Electrophysiological Study (full–2016) http://journal.frontiersin.org/article/10.3389/fncel.2016.00077/full
Cannabis for posttraumatic stress disorder: A neurobiological approach to treatment (full–2016) http://journals.lww.com/tnpj/Fulltext/2016/01000/Cannabis_for_posttraumatic_stress_disorder__A.6.aspx
Synthetic Ligands of Cannabinoid Receptors Affect Dauer Formation in the Nematode Caenorhabditis elegans (full–2016) http://www.g3journal.org/content/early/2016/04/11/g3.116.026997.long
Impaired Ethanol-Induced Sensitization and Decreased Cannabinoid Receptor-1 in a Model of Posttraumatic Stress Disorder (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0155759#pone.0155759.ref024
Neuronal and Astrocytic Monoacylglycerol Lipase Limit the Spread of Endocannabinoid Signaling in the Cerebellum (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865651/
Cannabinoid receptor type-1: breaking the dogmas (full–2016) http://f1000research.com/articles/5-990/v1 CB2 Cannabinoid Receptor As Potential Target against Alzheimer’s Disease (full–2016) http://journal.frontiersin.org/article/10.3389/fnins.2016.00243/full#B36
p21-activated kinase 1 restricts tonic endocannabinoid signaling in the hippocampus (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4907698/
Endocannabinoid Modulation of Orbitostriatal Circuits Gates Habit Formation (full–2016) http://www.cell.com/neuron/fulltext/S0896-6273%2816%2930157-X
Stimulation of brain glucose uptake by cannabinoid CB2 receptors and its therapeutic potential in Alzheimer’s disease (full–2016) http://www.sciencedirect.com/science/article/pii/S0028390816300879
Amyloid proteotoxicity initiates an inflammatory response blocked by cannabinoids (full–2016) http://www.nature.com/articles/npjamd201612
Enkephalin levels and the number of neuropeptide Y-containing interneurons in the hippocampus are decreased in female cannabinoid-receptor 1 knock-out mice (full–2016) http://www.sciencedirect.com/science/article/pii/S0304394016301689
Impaired Excitatory Neurotransmission in the Urinary Bladder from the Obese Zucker Rat: Role of Cannabinoid Receptors (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4902197/
Endocannabinoid control of glutamate NMDA receptors: the therapeutic potential and consequences of dysfunction (full–2016) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path %5B%5D=10095&path%5B%5D=31745
L-type calcium channels and MAP kinase contribute to thyrotropin-releasing hormone induced depolarization in thalamic paraventricular nucleus neurons (full–2016) http://ajpregu.physiology.org/content/310/11/R1120.long
Medullary Endocannabinoids Contribute to the Differential Resting Baroreflex Sensitivity in Rats with Altered Brain Renin-Angiotensin System Expression (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4899471/
Effect of interaction between acute administration of morphine and cannabinoid compounds on spontaneous excitatory and inhibitory postsynaptic currents of magnocellular neurons of supraoptic nucleus (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951608/
Orexins contribute to restraint stress-induced cocaine relapse by endocannabinoid mediated disinhibition of dopaminergic neurons (full–2016) http://www.nature.com/ncomms/2016/160722/ncomms12199/full/ncomms12199.html
Endocannabinoids and Heterogeneity of Glial Cells in Brain Function (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4932105/
Orchestrated activation of mGluR5 and CB1 promotes neuroprotection (full–2016) http://molecularbrain.biomedcentral.com/articles/10.1186/s13041-016-0259-6
A role of CB1R in inducing θ-rhythm coordination between the gustatory and gastrointestinal insula (full–2016) http://www.nature.com/articles/srep32529
Targeting Cannabinoid CB2 Receptors in the Central Nervous System. Medicinal Chemistry Approaches with Focus on Neurodegenerative Disorders (full–2016) http://journal.frontiersin.org/article/10.3389/fnins.2016.00406/full
Biased Agonism of Three Different Cannabinoid Receptor Agonists in Mouse Brain Cortex (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00415/full
fMRI study of neural sensitization to hedonic stimuli in long-term, daily cannabis users (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012952/
Individual differences in frontolimbic circuitry and anxiety emerge with adolescent changes in endocannabinoid signaling across species (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4843434/
Cannabinoids reverse the effects of early stress on neurocognitive performance in adulthood (full–2016) http://learnmem.cshlp.org/content/23/7/349.long
Ontogeny of sensorimotor gating and short-term memory processing throughout the adolescent period in rats (full–2016) http://www.sciencedirect.com/science/article/pii/S1878929316300639
Acetylcholine receptors from human muscle as pharmacological targets for ALS therapy. (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801305/
Mild Traumatic Brain Injury Produces Neuron Loss That Can Be Rescued by Modulating Microglial Activation Using a CB2 Receptor Inverse Agonist (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052277/
Orexin-A represses satiety-inducing POMC neurons and contributes to obesity via stimulation of endocannabinoid signaling (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4855580/
CB2 receptor activation prevents glial-derived neurotoxic mediator production, BBB leakage and peripheral immune cell infiltration and rescues dopamine neurons in the MPTP model of Parkinson’s disease (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4892852/
Target-specific modulation of the descending prefrontal cortex inputs to the dorsal raphe nucleus by cannabinoids (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4868450/
Neurophysiology of space travel: energetic solar particles cause cell type-specific plasticity of neurotransmission (full–2016) http://link.springer.com/article/10.1007%2Fs00429-016-1345-3
Target regulation of PI3K/Akt/mTOR pathway by cannabidiol in treatment of experimental multiple sclerosis (full–2016) http://www.sciencedirect.com/science/article/pii/S0367326X16304476
Diacylglycerol lipase disinhibits VTA dopamine neurons during chronic nicotine exposure. (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4743781/
Cannabidiol Counteracts Amphetamine-Induced Neuronal and Behavioral Sensitization of the Mesolimbic Dopamine Pathway through a Novel mTOR/p70S6 Kinase Signaling Pathway (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854973/
Spatial Distribution of the Cannabinoid Type 1 and Capsaicin Receptors May Contribute to the Complexity of Their Crosstalk (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5032030/
Coordinated regulation of endocannabinoid-mediated retrograde synaptic suppression in the cerebellum by neuronal and astrocytic monoacylglycerol lipase (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5075776/
Endocannabinoid signaling regulates regenerative axon navigation in Caenorhabditis elegans via the GPCRs NPR-19 and NPR-32 (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/gtc.12377/full
Alteration of SLP2‐like immunolabeling in mitochondria signifies early cellular damage in developing and adult mouse brain (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4784115/
Cannabidiol attenuates OGD/R-induced damage by enhancing mitochondrial bioenergetics and modulating glucose metabolism via pentose-phosphate pathway in hippocampal neurons (full–2016) http://www.sciencedirect.com/science/article/pii/S221323171630338X
Benefits from Cannabinoids (article-1st page–2016) http://www.cell.com/cell/abstract/S0092-8674(16)31675-0?_returnURL=http%3A%2F %2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0092867416316750%3Fshowall%3Dtrue
Suppressing Schizophrenia Symptoms Without Side Effects: Mouse Study (news & abst–2016) http://neurosciencenews.com/schizophrenia-compound-striatum-5089/
Acute Neurologic Disorder from an Inhibitor of Fatty Acid Amide Hydrolase (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27806235 Lipids in psychiatric disorders and preventive medicine (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763415303353
Physiological impact of CB1 receptor expression by hippocampal GABAergic interneurons (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26739712
Major dorsoventral differences in the modulation of the local CA1 hippocampal network by NMDA, mGlu5, adenosine A2A and cannabinoid CB1 receptors (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26762803
The endocannabinoid system and neuropathic pain (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26785153
Dentate cannabinoid-sensitive interneurons undergo unique and selective strengthening of mutual synaptic inhibition in experimental epilepsy (abst–2016) http://www.sciencedirect.com/science/article/pii/S0969996116300146
Dentate cannabinoid-sensitive interneurons undergo unique and selective strengthening of mutual synaptic inhibition in experimental epilepsy (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26804027 Expression of functional cannabinoid CB2 receptor in VTA dopamine neurons in rats (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26833913
Stimulation of cannabinoid CB1 receptors prevents nerve-mediated airway hyperreactivity in NGF-induced inflammation in mouse airways (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26896777
The Hyperpolarization-Activated Cation Current Ih: The Missing Link Connecting Cannabinoids to Cognition (abst–2016) http://www.cell.com/neuron/abstract/S0896-6273(16)00144-6?_returnURL=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0896627316001446%3Fshowall%3Dtrue
Nutritional n-3 PUFA Deficiency Abolishes Endocannabinoid Gating of Hippocampal Long-Term Potentiation (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26946127 Functional effects of cannabinoids during dopaminergic specification of human neural precursors derived from induced pluripotent stem cells (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27027565
Antagonism of dopamine receptor 2 long (D2L) affects cannabinoid receptor 1 (CB1) signaling in a cell culture model of striatal medium spiny projection neurons (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27053685
Targeting the cannabinoid CB2 receptor to attenuate the progression of motor deficits in LRRK2-transgenic mice. (abst – 2016) http://www.sciencedirect.com/science/article/pii/S1043661816302663
Distinct neuronal activation patterns are associated with PCP-induced social withdrawal and its reversal by the endocannabinoid-enhancing drug URB597. (abst – 2016) http://www.sciencedirect.com/science/article/pii/S0168010216300220
Broad impact of deleting endogenous cannabinoid hydrolyzing enzymes and the CB1 cannabinoid receptor on the endogenous cannabinoid-related lipidome in eight regions of the mouse brain. (abst – 2016) http://www.sciencedirect.com/science/article/pii/S1043661816303449
WHERE’s MY ENTOURAGE? THE CURIOUS CASE OF 2-oleoylglycerol, 2- linolenoylglycerol, and 2-palmitoylglycerol. (abst – 2016) http://www.sciencedirect.com/science/article/pii/S1043661816303346
Endocannabinoid 2-Arachidonoylglycerol Suppresses LPS-Induced Inhibition of A-Type Potassium Channel Currents in Caudate Nucleus Neurons Through CB1 Receptor (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27129498
Cannabinoid Type 2 Receptors Mediate a Cell Type-Specific Plasticity in the Hippocampus (abst–2016) http://www.cell.com/neuron/abstract/S0896-6273%2816%2930025-3
Stimulated CB1 Cannabinoid Receptor Inducing Ischemic Tolerance and Protecting Neuron from Cerebral Ischemia. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27142423
Direct presynaptic and indirect astrocyte-mediated mechanisms both contribute to endocannabinoid signaling in the pedunculopontine nucleus of mice. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27169390
Phytocannabinoids and cannabimimetic drugs: recent patents in central nervous system disorders. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27184693
Inhibition of Endocannabinoid Degradation Improves Outcomes from Mild Traumatic Brain Injury: A Mechanistic Role for Synaptic Hyperexcitability. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27189876
Differences in Chloride Gradients Allow for Three Distinct Types of Synaptic Modulation by Endocannabinoids. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27226449
Pharmacological characterization of emerging synthetic cannabinoids in HEK293T cells and hippocampal neurons. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27260125
Effect of synthetic cannabinoids on spontaneous neuronal activity: Evaluation using Ca2+ spiking and multi-electrode arrays. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27262380
Aberrant epilepsy-associated mutant Nav1.6 sodium channel activity can be targeted with cannabidiol. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27267376
Reduced Noradrenergic Signaling in the Spleen Capsule in the Absence of CB1 and CB2 Cannabinoid Receptors. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27287619
Upregulation of the cannabinoid CB2 receptor in environmental and viral inflammation driven rat models of Parkinson’s disease. (abst – 2016) http://www.sciencedirect.com/science/article/pii/S0014488616301790
Ischemic Stroke, Excitatory Amino Acids Toxicity and the Adjustment of Acupuncture Intervention (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27323449
FABP1 in wonderland. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27329821
Cannabinoids and Neuro-Inflammation: Regulation of Brain Immune Response. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27334610
Microglia activation states and cannabinoid system: Therapeutic implications. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27373505
Inhibitors of diacylglycerol lipases in neurodegenerative and metabolic disorders. (abst – 2016) http://www.sciencedirect.com/science/article/pii/S0960894X16306874
Expression of the Endocannabinoid Receptor 1 in Human Stroke: An Autoptic Study. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27425766
Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 may protect against cognitive impairment in rats of chronic cerebral hypoperfusion via PI3K/AKT signaling. (abst – 2016) http://www.sciencedirect.com/science/article/pii/S0166432816304375
Projection-Specific Dynamic Regulation of Inhibition in Amygdala Micro-Circuits (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27497223
Acute Stress Suppresses Synaptic Inhibition and Increases Anxiety via Endocannabinoid Release in the Basolateral Amygdala. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27511017
Peripheral and central CB1 cannabinoid receptors control stress-induced impairment of memory consolidation. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27528659
Regulated endosomal trafficking of Diacylglycerol lipase alpha (DAGLα) generates distinct cellular pools; implications for endocannabinoid signaling. (abst – 2016) http://www.sciencedirect.com/science/article/pii/S104474311630135X
PAK1 regulates inhibitory synaptic function via a novel mechanism mediated by endocannabinoids. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27645771
Cannabinoids: Glutamatergic Transmission and Kynurenines. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27651254
Restricted vs. unrestricted wheel running in mice: Effects on brain, behavior and endocannabinoids. (abst – 2016) http://www.sciencedirect.com/science/article/pii/S0018506X16301799
Functions of synapse adhesion molecules neurexin/neurexins and neurodevelopmental disorders. (abst – 2016) http://www.sciencedirect.com/science/article/pii/S0168010216301419
Interaction between hippocampal serotonin and cannabinoid systems in reactivity to spatial and object novelty detection. (abst – 2016) http://www.sciencedirect.com/science/article/pii/S016643281630715X CB1
Cannabinoid Receptors Mediate Cognitive Deficits and Structural Plasticity Changes During Nicotine Withdrawal. (abst – 2016) https://www.ncbi.nlm.nih.gov/pubmed/27737762
Chronic stress leads to epigenetic dysregulation of neuropeptide-Y and cannabinoid CB1 receptor in the mouse cingulate cortex. (abst – 2016) http://www.sciencedirect.com/science/article/pii/S0028390816304580
Cannabinoids prevent the amyloid β-induced activation of astroglial hemichannels: A neuroprotective mechanism. (abst – 2016) https://www.ncbi.nlm.nih.gov/pubmed/27757991
Descending serotonergic and noradrenergic systems do not regulate the antipruritic effects of cannabinoids. (abst – 2016) https://www.cambridge.org/core/journals/acta-neuropsychiatrica/article/descending-serotonergic-andnoradrenergic-systems-do-not-regulate-the-antipruritic-effects-ofcannabinoids/5BE6C9C7BA28268807D522354F70199A
The central cannabinoid receptor type-2 (CB2) and chronic pain. (abst – 2016) https://www.ncbi.nlm.nih.gov/pubmed/27842450
Regulation of fear extinction by long-term depression: the roles of endocannabinoids and brain derived neurotrophic factor. (abst – 2016) https://www.ncbi.nlm.nih.gov/pubmed/27867101
The cannabinoid beta-caryophyllene (BCP) induces neuritogenesis in PC12 cells by a cannabinoid-receptor-independent mechanism. (abst – 2016) http://www.sciencedirect.com/science/article/pii/S0009279716305920
Cannabidiol reduces neuroinflammation and promotes neuroplasticity and functional recovery after brain ischemia. (abst – 2016) http://www.sciencedirect.com/science/article/pii/S0278584616302524
Cannabinoid Type-2 Receptor Drives Neurogenesis and Improves Functional Outcome After Stroke. (abst – 2016) https://www.ncbi.nlm.nih.gov/pubmed/27899748
Cannabidiol Activates Neuronal Precursor Genes in Human Gingival Mesenchymal Stromal Cells. (abst – 2016) https://www.ncbi.nlm.nih.gov/pubmed/27918106
Role of Cannabinoid Receptor Type 1 in Tibial and Pudendal Neuromodulation of Bladder Overactivity in Cats. (abst – 2016) https://www.ncbi.nlm.nih.gov/pubmed/27927655
Inflammation of peripheral tissues and injury to peripheral nerves induce diferring effects in the expression of the calcium-sensitive anandamide-synthesising enzyme and related molecules in rat primary sensory neurons. (abst – 2016) https://www.ncbi.nlm.nih.gov/pubmed/27997038
Inhibitors of oxidative and hydrolytic endocannabinoid degradation do not enhance depolarization-induced suppression of excitation on dorsal cochlear nucleus glycinergic neurons. (abst – 2016) https://www.ncbi.nlm.nih.gov/pubmed/27997730
Muscarinic acetylcholine receptors control baseline activity and Hebbian stimulus-timing dependent plasticity in fusiform cells of the dorsal cochlear nucleus. (abst – 2016) https://www.ncbi.nlm.nih.gov/pubmed/28003407
Synaptic Reorganization of the Perisomatic Inhibitory Network in Hippocampi of Temporal Lobe Epileptic Patients (full – 2017) https://www.hindawi.com/journals/bmri/2017/7154295/
Singular Location and Signaling Profile of Adenosine A2A-Cannabinoid CB1 Receptor Heteromers in the Dorsal Striatum. (link to download – 2017) http://www.nature.com/npp/journal/vaop/naam/abs/npp201712a.html
Brain cannabinoid receptor 2: expression, function and modulation. (abst – 2017) https://www.ncbi.nlm.nih.gov/pubmed/28065934
(S)Pot on Mitochondria: Cannabinoids Disrupt Cellular Respiration to Limit Neuronal Activity (abst – 2017) https://www.ncbi.nlm.nih.gov/pubmed/28076767
N-Oleoylglycine-induced hyperphagia was associated with the activation of AgRP neuron by CB1R. (abst – 2017) https://www.ncbi.nlm.nih.gov/pubmed/28102080
Effect of inhibition of fatty acid amide hydrolase on MPTP-induced dopaminergic neuronal damage. (abst – 2017) https://www.ncbi.nlm.nih.gov/pubmed/28104279
Endocannabinoid 2-arachidonoylglycerol protects inflammatory insults from sulfur dioxide inhalation via cannabinoid receptors in the brain (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28115138
Antihyperalgesic effect of CB1 receptor activation involves the modulation of P2X3 receptor in the primary afferent neuron (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28131783


NEUROPATHIC PAIN
Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type I diabetic peripheral neuropathic pain (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2845559/?tool=pmcentrez
R-Flurbiprofen Reduces Neuropathic Pain in Rodents by Restoring Endogenous Cannabinoids (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2869361/
Pharmacological Treatment of Painful HIV-Associated Sensory Neuropathy: A Systematic Review and Meta-Analysis of Randomised Controlled Trials (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3010990/?tool=pmcentrez
Smoked cannabis for chronic neuropathic pain: a randomized controlled trial (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2950205/?tool=pmcentrez
Pharmacological characterization of a novel cannabinoid ligand, MDA19, for treatment of neuropathic pain (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253719/
Combination Of Cannabinoids For The Treatment Of Peripheral Neuropathic Pain US 2010/ 0035978 A1 Feb. 11, 2010 (full–2010) http://www.cannabisinternational.org/info/Neuropathic-Pain.pdf
top
Misdiagnosed chronic pelvic pain: pudendal neuralgia responding to a novel use of palmitoylethanolamide (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20345619
AMELIORATIVE POTENTIAL OF CANNABIS SATIVA EXTRACT ON DIABETES INDUCED NEUROPATHIC PAIN IN RATS (full–2010) http://www.ijpsr.com/V1I11/11%20Vol%201,%20Issue%2011,%20IJPSR,%20Paper%206.pdf
An Open-Label Comparison of Nabilone and Gabapentin as Adjuvant Therapy or Monotherapy in the Management of Neuropathic Pain in Patients with Peripheral Neuropathy (abst–2010) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=311
Effect of dronabinol on central neuropathic pain after spinal cord injury: a pilot study (abst–2010) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=313
Cannabinoid subtype-2 receptors modulate the antihyperalgesic effect of WIN 55,212-2 in rats with neuropathic spinal cord injury pain (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20920894
Brief Report: Cannabidiol Prevents the Development of Cold and Mechanical Allodynia in Paclitaxel-Treated Female C57Bl6 Mice (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249239/
Cannabinoid Agonists Inhibit Neuropathic Pain Induced by Brachial Plexus Avulsion in Mice by Affecting Glial Cells and MAP Kinases (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3172222/?tool=pubmed
Self-medication of a cannabinoid CB(2) agonist in an animal model of neuropathic pain (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3157548/pdf/nihms285774.pdf
Cannabinoids for Treatment of Chronic Non-Cancer Pain; a Systematic Review of Randomized Trials (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3243008/
Mutations in ABHD12 cause the neurodegenerative disease PHARC: An inborn error of endocannabinoid metabolism (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2933347/?tool=pubmed
Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085542/
Activation of spinal and supraspinal cannabinoid-1 receptors leads to anti-nociception in a rat model of neuropathic spinal cord injury pain (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3159760/
Spinal cannabinoid CB2 receptors as a target for neuropathic pain: an investigation using chronic constriction injury (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22210507
Palmitoylethanolamide restores myelinated-fibre function in patients with chemotherapy induced painful neuropathy (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22229320
Prescribing Cannabis for Harm Reduction (full–2012) http://www.harmreductionjournal.com/content/pdf/1477-7517-9-1.pdf
top
The maintenance of cisplatin- and paclitaxel-induced mechanical and cold allodynia is suppressed by cannabinoid CB2 receptor activation and independent of CXCR4 signaling in models of chemotherapy-induced peripheral neuropathy (full–2012) http://www.molecularpain.com/content/8/1/71
Therapeutic utility of palmitoylethanolamide in the treatment of neuropathic pain associated with various pathological conditions: a case series (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3500919/
Endocannabinoids in nervous system health and disease: the big picture in a nutshell (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3193.full
The Therapeutic Potential of Cannabis and Cannabinoids (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442177/
The major brain endocannabinoid 2-AG controls neuropathic pain and mechanical hyperalgesia in patients with neuromyelitis optica (full–2012) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0071500
Dynamic changes to the endocannabinoid system in models of chronic pain (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3300.full?sid=1569c370-cd5c-4358-89ff-857201f5e069
Low-Dose Vaporized Cannabis Significantly Improves Neuropathic Pain (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3566631/
Modulation of neuropathic-pain-related behaviour by the spinal endocannabinoid / endovanilloid system (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3481534/
Prevention of Paclitaxel-Induced Neuropathy Through Activation of the Central Cannabinoid Type 2 Receptor System (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334436/
The Novel Reversible Fatty Acid Amide Hydrolase Inhibitor ST4070 Increases Endo-cannabinoid Brain Levels and Counteracts Neuropathic Pain in Different Animal Models (full–2012) http://jpet.aspetjournals.org/content/342/1/188.full.pdf+html
Peripheral FAAH inhibition causes profound antinociception and protects against indomethacin-induced gastric lesions (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738192/
Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3371734/
Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525790/
Local Peripheral Effects of β-Caryophyllene through CB2 Receptors in Neuropathic Pain in Mice (full – 2012) http://file.scirp.org/Html/23613.html
Multimodal stepped care approach with acupuncture and PPAR-α agonist palmitoylethanolamide in the treatment of a patient with multiple sclerosis and central neuropathic pain. (full – 2012) http://aim.bmj.com/content/30/1/53.long
The atypical cannabinoid O-1602 increases hind paw sensitisation in the chronic constriction injury model of neuropathic pain (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22227298
top
Cannabinoid agonist WIN 55,212-2 prevents the development of paclitaxel-induced peripheral neuropathy in rats. Possible involvement of spinal glial cells (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22374260
Low brain penetrant CB1 receptor agonists for the treatment of neuropathic pain (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22421020
Characterization of cannabinoid-induced relief of neuropathic pain in rat models of type 1 and type 2 diabetes (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22609797
A Randomized, Double-Blind, Placebo Controlled, Parallel Assignment, Flexible Dose, Efficacy Study of Nabilone as Adjuvant in the Treatment of Diabetic Peripheral Neuropathic Pain Using an Enriched Enrollment Randomized Withdrawal Design (S38.003) (abst–2012) http://www.neurology.org/cgi/content/meeting_abstract/78/1_MeetingAbstracts/S38.003?maxtoshow=&hits=25&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=180&sortspec=date&resourcetype=HWCIT
An enriched-enrolment, randomized withdrawal, flexible-dose, double-blind, placebo controlled, parallel assignment efficacy study of nabilone as adjuvant in the treatment of diabetic peripheral neuropathic pain (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22921260
Peripheral antinociceptive effect of anandamide and drugs that affect the endocannabinoid system on the formalin test in normal and streptozotocin-diabetic rats (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22959964
A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23180178
The Major Brain Endocannabinoid 2-AG Controls Neuropathic Pain and Mechanical Hyperalgesia in Patients with Neuromyelitis Optica (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0071500
Drug Design for Neuropathic Pain Regulation from Traditional Chinese Medicine (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3558695/
Full Inhibition of Spinal FAAH Leads to TRPV1-Mediated Analgesic Effects in Neuropathic Rats and Possible Lipoxygenase-Mediated Remodeling of Anandamide Metabolism (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0060040
The cannabinoid CB2 receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain (full–2013) http://www.europeanneuropsychopharmacology.com/article/S0924-977X%2813%2900302-7/fulltext
The endocannabinoid system, cannabinoids, and pain (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820295/
Bilateral changes of cannabinoid receptor type 2 protein and mRNA in the dorsal root ganglia of a rat neuropathic pain model (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3707359/
A Double-Blind, Placebo-Controlled, Crossover Pilot Trial With Extension Using an Oral Mucosal Cannabinoid Extract for Treatment of Chemotherapy-Induced Neuropathic Pain (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23742737
A Double-Blind, Placebo-Controlled, Crossover Pilot Trial With Extension Using an Oral Mucosal Cannabinoid Extract for Treatment of Chemotherapy-Induced Neuropathic Pain (full–2013) http://www.jpsmjournal.com/article/S0885-3924%2813%2900238-8/fulltext
Anandamide deficiency and heightened neuropathic pain in aged mice (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23597506
Non-Neuronal Cell Modulation Relieves Neuropathic Pain: Efficacy of the Endogenous Lipid Palmitoylethanolamide (link to PDF–2013) http://www.eurekaselect.com/107974/article
Palmitoylethanolamide Reduces Formalin-Induced Neuropathic-Like Behaviour Through Spinal Glial/Microglial Phenotypical Changes in Mice (link to PDF–2013) http://www.eurekaselect.com/107975/article
Different Classes of CB2 Ligands Potentially Useful in the Treatment of Pain (link to PDF–2013) http://www.eurekaselect.com/108399/article
Medicinal Cannabis and Painful Sensory Neuropathy (editorial–2013) http://virtualmentor.ama-assn.org/2013/05/oped1-1305.html
Therapeutic potential of cannabinoid medicines (full–2013) http://onlinelibrary.wiley.com/doi/10.1002/dta.1529/full
top
Characterisation of cannabinoid-induced relief of neuropathic pain in a rat model of cisplatin-induced neuropathy (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23454533
Palmitoylethanolamide is a New Possible Pharmacological Treatment for the Inflammation Associated with Trauma (abst–2013) http://www.eurekaselect.com/106175/article
Activation of spinal cannabinoid cb2 receptors inhibits neuropathic pain in streptozotocin-induced diabetic mice (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23892011
Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CB1 and CB2 receptors (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/24148808
Non-neuronal cell modulation relieves neuropathic pain: efficacy of the endogenous lipid palmitoylethanolamide (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23394519
Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT1A receptors without diminishing nervous system function or chemotherapy efficacy (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24117398
Prescribing smoked cannabis for chronic noncancer pain: Preliminary recommendations (full–2014) http://www.cfp.ca/content/60/12/1083.long
Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT1A receptors
without diminishing nervous system function or chemotherapy efficacy (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3969077/
Prophylactic cannabinoid administration blocks the development of paclitaxel-induced neuropathic nociception during analgesic treatment and following cessation of drug delivery (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998744/
top
Therapeutic benefits of cannabis: a patient survey (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998228/
CB2 cannabinoid receptors as a therapeutic target – What does the future hold? (full–2014) http://molpharm.aspetjournals.org/content/early/2014/08/08/mol.114.094649.long
Alterations in the anandamide metabolism in the development of neuropathic pain (full–2014) http://www.hindawi.com/journals/bmri/2014/686908/
NMP-7 inhibits chronic inflammatory and neuropathic pain via block of Cav3.2 T-type calcium channels and activation of CB2 receptors (full– 2014) http://www.molecularpain.com/content/pdf/1744-8069-10-77.pdf
Celastrol Attenuates Inflammatory and Neuropathic Pain Mediated by Cannabinoid Receptor Type 2 (link to PDF–2014) http://www.mdpi.com/1422-0067/15/8/13637
Glucose concentration in culture medium affects mRNA expression of TRPV1 and CB1 receptors and changes capsaicin toxicity in PC12 cells (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4322151/
Hemopressin, an inverse agonist of cannabinoid receptors, inhibits neuropathic pain in rats (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112957/
Effects of repeated dosing with mechanistically distinct antinociceptive ligands in a rat model of neuropathic spinal cord injury pain (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25505583
Effects of repeated dosing with mechanistically distinct antinociceptive ligands in a rat model of neuropathic spinal cord injury pain (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184706/
The cannabinoid CB₂ receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain (full–2014) http://www.europeanneuropsychopharmacology.com/article/S0924-977X%2813%2900302-7/fulltext
JZL184 is anti-hyperalgesic in a murine model of cisplatin-induced peripheral neuropathy (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25304184
JZL184 is anti-hyperalgesic in a murine model of cisplatin-induced peripheral neuropathy (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4268146/
Combined inhibition of FAAH and COX produces enhanced anti-allodynic effects in mouse neuropathic and inflammatory pain models (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4206939/
Inhibition of anandamide hydrolysis attenuates nociceptor sensitization in a murine model of chemotherapy-induced peripheral neuropathy (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25505113
Inhibition of anandamide hydrolysis attenuates nociceptor sensitization in a murine model of chemotherapy-induced peripheral neuropathy (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4346731/
Dual inhibition of monoacylglycerol lipase and cyclooxygenases synergistically reduces neuropathic pain in mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25393148
Dual inhibition of monoacylglycerol lipase and cyclooxygenases synergistically reduces neuropathic pain in mice (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376450/
Metabolomics uncovers dietary omega-3 fatty acid-derived metabolites implicated in anti-nociceptive responses after experimental spinal cord injury (full–2014) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3844071/
The Pharmacokinetics, Efficacy, Safety, and Ease of Use of a Novel Portable Metered Dose Cannabis Inhaler in Patients With Chronic Neuropathic Pain: A Phase 1a Study (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25118789
The Pharmacokinetics, Efficacy, Safety, and Ease of Use of a Novel Portable MeteredDose Cannabis Inhaler in Patients With Chronic Neuropathic Pain: A Phase 1a Study (full–2014) http://www.tandfonline.com/doi/full/10.3109/15360288.2014.941130
Pharmacological management of chronic neuropathic pain: Revised consensus statement from the Canadian Pain Society. (link to PDF – 2014) http://www.hindawi.com/journals/prm/2014/754693/abs/
A double-blind, randomized, placebo-controlled, parallel group study of THC/CBD spray in peripheral neuropathic pain treatment (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24420962
top
Endocannabinoids and neuropathic pain: focus on neuron-glia and endocannabinoid neurotrophin interactions (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24494680
Involvement of the endocannabinoid system in osteoarthritis pain (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24494687
Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24836296
Augmented tonic pain-related behavior in knockout mice lacking monoacylglycerol lipase, a major degrading enzyme for the endocannabinoid 2-arachidonoylglycerol (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24906199
Cannabinoids for Neuropathic Pain (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25160710
Neuropathic orofacial pain: Cannabinoids as a therapeutic avenue (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25150831
There is evidence for the use of cannabinoids for symptomatic treatment of multiple sclerosis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25350886
Attenuation of persistent pain-related behavior by fatty acid amide hydrolase (FAAH) inhibitors in a rat model of HIV sensory neuropathy (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25486617
Discriminating the effects of Cannabis sativa and Cannabis indica: a web survey of medical cannabis users (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25191852
top
Palmitoylethanolamide, a naturally occurring disease-modifying agent in neuropathic pain (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24178954
The spinal anti-inflammatory mechanism of motor cortex stimulation: cause of success and refractoriness in neuropathic pain? (full–2015) http://www.jneuroinflammation.com/content/pdf/s12974-014-0216-1.pdf
Nabilone as an Adjunctive to Gabapentin for Multiple Sclerosis-Induced Neuropathic Pain: A Randomized Controlled Trial (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/pme.12569/full
Cannabis in cancer care (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/cpt.108/full
Coadministration of indomethacin and minocycline attenuates established paclitaxel induced neuropathic thermal hyperalgesia: Involvement of cannabinoid CB1 receptors (full–2015) http://www.nature.com/srep/2015/150618/srep10541/pdf/srep10541.pdf
Efficacy and adverse effects of medical marijuana for chronic noncancer pain: Systematic review of randomized controlled trials (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4541447/
TRPV1 channel inhibition contributes to the antinociceptive effects of Croton macrostachyus extract in mice (full–2015) http://bmccomplementalternmed.biomedcentral.com/articles/10.1186/s12906-015-0816-z
CB1 Knockout Mice Unveil Sustained CB2-Mediated Anti-Allodynic Effects of the Mixed CB1/CB2 Agonist CP55,940 in a Mouse Model of Paclitaxel-Induced Neuropathic Pain (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25904556
Selective Monoacylglycerol Lipase Inhibitors: Antinociceptive versus Cannabimimetic Effects in Mice (abst–2015) http://jpet.aspetjournals.org/content/353/2/424.abstract?sid=97527854-e2fb-4d74-ad96-6ab0744dc240
Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review (full–2015) http://jama.jamanetwork.com/article.aspx? articleid=2338266
Combined inhibition of monoacylglycerol lipase and cyclooxygenases synergistically reduces neuropathic pain in mice (abst–2015) http://onlinelibrary.wiley.com/doi/10.1111/bph.13012/abstract
Efficacy of Inhaled Cannabis on Painful Diabetic Neuropathy (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25843054
A Cannabinoid CB1 Receptor Positive Allosteric Modulator Reduces Neuropathic Pain in the Mouse with no Psychoactive Effects (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26052038
Spinal RGS4 inhibition effectively attenuates neuropathic hyperalgesia and restores cannabinoid receptor type 1 signaling (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26478461
Inhaled Cannabis for Chronic Neuropathic Pain: A Meta-analysis of Individual Patient Data (abst–2015) http://www.jpain.org/article/S1526-5900%2815%2900812-3/abstract
Tonic Modulation of Nociceptive Behavior and Allodynia by Cannabinoid Receptors in Formalin Test in Rats (full–2015) http://www.cps.org.tw/files/201503160252300.pdf
Medical marijuana: Hints of headway? Despite a conflicted regulatory landscape, support for medical marijuana is growing amid increasing evidence of potential benefits (Part 2 of 2) (article–2015) http://onlinelibrary.wiley.com/doi/10.1002/cncy.21524/full
The entourage effect: Synergistic actions of plant cannabinoids (letter–2015) http://www.researchgate.net/publication/273330402_The_entourage_effect_Synergistic_actions_of_plant_cannabinoids
The Effectiveness of Cannabinoids in the Management of Chronic Nonmalignant Neuropathic Pain: A Systematic Review (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25635955
Influence of nitric oxide synthase or cyclooxygenase inhibitors on cannabinoids activity in streptozotocin-induced neuropathy (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25712641
CB1 receptors modulate affective behaviour induced by neuropathic pain (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25863168
top
N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26055231
Minimizing chemotherapy-induced peripheral neuropathy: preclinical and clinical development of new perspectives (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26058312
Medical Marijuana and Chronic Pain: a Review of Basic Science and Clinical Evidence (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26325482
The Efficacy of Eslicarbazepine Acetate in Models of Trigeminal, Neuropathic, and Visceral Pain: The Involvement of 5-HT1B/1D Serotonergic and CB1/CB2 Cannabinoid Receptors (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26465930
Analysis of the anti-allodynic effects of combination of a synthetic cannabinoid and a selective noradrenaline re-uptake inhibitor in nerve injury-induced neuropathic mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26206340
Prescribing medical cannabis in Canada: Are we being too cautious? (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26451996
Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine neuropathic pain model (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/bph.13337/full
Integrating cannabis into clinical cancer care (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791148/
The effect of spinally administered WIN 55,212-2, a cannabinoid agonist, on thermal pain sensitivity in diabetic rats (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4887712/
Neuropathic Pain Treatment: Still a Challenge (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4935814/
Cannabinoid Buccal Spray for Chronic Non-Cancer or Neuropathic Pain: A Review of Clinical Effectiveness, Safety, and Guidelines (full–2016) https://www.ncbi.nlm.nih.gov/books/NBK395789/
A preliminary evaluation of the relationship of cannabinoid blood concentrations with the analgesic response to vaporized cannabis (link to PDF–2016) https://www.dovepress.com/a-preliminary-evaluation-of-the-relationship-of-cannabinoid-blood-conc-peerreviewed-article-JPR
The selective monoacylglycerol lipase inhibitor MJN110 produces opioid sparing effects in a mouse neuropathic pain model (link to PDF–2016) http://jpet.aspetjournals.org/content/early/2016/01/20/jpet.115.229971.abstract?sid=97527854 -e2fb-4d74-ad96-6ab0744dc240
Using Medical Cannabis in an Oncology Practice (article–2016) (needs free registration) http://www.cancernetwork.com/oncology-journal/using-medical-cannabis-oncologypractice#sthash.CjT8fR9n.uWvEhfSG.dpuf Using Medical Cannabis in an Oncology Practice (1st page – 2016) http://www.cancernetwork.com/oncology-journal/using-medical-cannabis-oncologypractice#sthash.CjT8fR9n.dpuf
Evaluating Sativex® in Neuropathic Pain Management: A Clinical and Neurophysiological Assessment in Multiple Sclerosis (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26764336
Medical use of cannabis products : Lessons to be learned from Israel and Canada (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26767992
The endocannabinoid system and neuropathic pain (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26785153
Efficacy, tolerability and safety of cannabinoids for chronic neuropathic pain : A systematic review of randomized controlled studies (scroll down for English version) (abst–2016) http://link.springer.com/article/10.1007%2Fs00482-015-0089-y Cannabinoids and autoimmune diseases: A systematic review (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26876387
Nabilone for the Management of Pain (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26923810
Polypharmacological Properties and Therapeutic Potential of β-Caryophyllene: a Dietary Phytocannabinoid of Pharmaceutical Promise (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26965491
Endovanilloid control of pain modulation by the rostroventromedial medulla in an animal model of diabetic neuropathy (abst–2016) http://www.sciencedirect.com/science/article/pii/S002839081630079X
The role of carbon monoxide on the anti-nociceptive effects and expression of cannabinoid 2 receptors during painful diabetic neuropathy in mice (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27020787
Mesoporous Silica Particles as a Multifunctional Delivery System for Pain Relief in Experimental Neuropathy (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27028159 Effects of Delta-9-Tetrahydrocannabinol and Cannabidiol on Cisplatin-Induced Neuropathy in Mice (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27214593
Opioid and cannabinoid synergy in a mouse neuropathic pain model (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27278681
The multiplicity of spinal AA-5-HT anti-nociceptive action in a rat model of neuropathic pain. (abst – 2016) http://www.sciencedirect.com/science/article/pii/S1043661816305667 Cannabinoids for the treatment of neuropathic pain (abst–2016) http://www.ingentaconnect.com/search/article?option1=title&value1=Cannabinoids+for+the+treatment+of+neuropathic+pain.&pageSize=10&index=1
An Exploratory Human Laboratory Experiment Evaluating Vaporized Cannabis in the Treatment of Neuropathic Pain from Spinal Cord Injury and Disease (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27286745
Peripherally selective cannabinoid 1 receptor (CB1R) agonists for the treatment of neuropathic pain (abst–2016) http://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.6b00516
Progress in study on endocannabinoids and cannabinoid receptors in the treatment for neuropathic pain (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27600019
Activation of Cannabinoid Receptor 2 Attenuates Mechanical Allodynia and Neuroinflammatory Responses in a Chronic Post-Ischemic Pain Model of Complex Regional Pain Syndrome Type I in Rats (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27717112
The endocannabinoid hydrolysis inhibitor SA-57: Intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in mice (abst–2016) http://www.sciencedirect.com/science/article/pii/S0028390816305123
Inflammation of peripheral tissues and injury to peripheral nerves induce diferring effects in the expression of the calcium-sensitive anandamide-synthesising enzyme and related molecules in rat primary sensory neurons (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27997038
Endocannabinoid activation of CB1 receptors contributes to long-lasting reversal of neuropathic pain by repetitive spinal cord stimulation (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28107590


NEUROPROTECTION
Neuroprotective potential of CB1 receptor agonists in an in vitro model of Huntington’s disease (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931573/?tool=pubmed
Learning and memory performances in adolescent users of alcohol and marijuana: interactive effects (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2965487/
The effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931570/?tool=pubmed
The Neuroprotective Effect of Cannabinoid Receptor Agonist (WIN55,212-2) in Paraoxon Induced Neurotoxicity in PC12 Cells and N-methyl-D-aspartate Receptor Interaction (full–2010) http://celljournal.org/library/upload/article/af_4334422Hashemi.pdf
THC Prevents MDMA Neurotoxicity in Mice (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2824821/
The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxicischemic brain damage in mice is mediated by CB(2) and adenosine receptors (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/19900555
Cannabinoid receptor agonist protects cultured dopaminergic neurons from the death by the proteasomal dysfunction (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3145842/?tool=pubmed
Inhibition of COX-2 expression by endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-γ (full–2011) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2011.01444.x/full
Cannabinoids and B cells: emerging targets for treating progressive multiple sclerosis (full–2011) http://msj.sagepub.com/content/17/3/259.long
N-arachidonoyl–serine is neuroprotective after traumatic brain injury by reducing apoptosis (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170948/
Cannabinoid Receptor Type 1 Protects Nigrostriatal Dopaminergic Neurons against MPTP Neurotoxicity by Inhibiting Microglial Activation (full–2011) http://www.jimmunol.org/content/187/12/6508.full?sid=c3422dd2-7ad0-42e4-a862-845dc670f7cf
Pharmacological activation/inhibition of the cannabinoid system affects alcohol withdrawal-induced neuronal hypersensitivity to excitotoxic insults (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3158793/
HIV-1 infection and alcohol abuse: neurocognitive impairment, mechanisms of neuro-degeneration and therapeutic interventions (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3098312/
Endocannabinoid 2-arachidonoylglycerol protects neurons against β-amyloid insults (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3052737/pdf/nihms266962.pdf
top
The dual neuroprotective-neurotoxic profile of cannabinoid drugs (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165949/
Cannabinoid-containing plant extracts as neuroprotective agents – Patent EP2332533 (A1) ― 2011-06-15 (full–2011) http://worldwide.espacenet.com/publicationDetails/description?CC=EP&NR=2332533A1&KC=A1&FT=D&ND=3&date=20110615&DB=EPODOC&locale=en_EP
Cannabinoids and Innate Immunity: Taking a Toll on Neuroinflammation (link to PDF–2011) http://www.tswj.com/2011/230786/abs/
Role of Cannabinoids in Multiple Sclerosis (link to PDF-2011) http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.659.8269&rank=26
Overexpression of CB2 cannabinoid receptors results in neuroprotection against behavioral and neurochemical alterations induced by intracaudate administration of 6-hydroxydopamine (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/20980074
The endocannabinoid anandamide downregulates IL-23 and IL-12 subunits in a viral model of multiple sclerosis: evidence for a cross-talk between IL-12p70/IL-23 axis and IL-10 in microglial cells (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21310228
Immunomodulatory properties of kappa opioids and synthetic cannabinoids in HIV-1 neuropathogenesis (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21850403
Effects of palmitoylethanolamide on release of mast cell peptidases and neurotrophic factors after spinal cord injury (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21354467
Functional and Structural Protection by N-Acylethanolamines in Diabetic Retinopathy (abst-2011) http://iovs.arvojournals.org/article.aspx?articleid=2356082&resultClick=1
Update on the role of cannabinoid receptors after ischemic stroke (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3337695/?tool=pubmed
Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-α. (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3315437/?tool=pubmed
Dimerization with Cannabinoid Receptors Allosterically Modulates Delta Opioid Receptor Activity during Neuropathic Pain (full–2012) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0049789
Contribution of Hypothermia and CB(1) Receptor Activation to Protective Effects of TAK-937, a Cannabinoid Receptor Agonist, in Rat Transient MCAO Model (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3397930/?tool=pubmed
Early Endogenous Activation of CB1 and CB2 Receptors after Spinal Cord Injury Is a Protective Response Involved in Spontaneous Recovery (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496738/
Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-α (full–2012) http://www.jneuroinflammation.com/content/9/1/49
Endocannabinoids in nervous system health and disease: the big picture in a nutshell (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3193.full
top
Intrinsic Up-Regulation of 2-AG Favors an Area Specific Neuronal Survival in Different In Vitro Models of Neuronal Damage (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3527460/
Review article: The endocannabinoid system in normal and pathological brain ageing (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3326.full?sid=161e7b36-5055-448b-962e-697c782e901d
Sativex-like Combination of Phytocannabinoids is Neuroprotective in Malonate-Lesioned Rats, an Inflammatory Model of Huntington’s Disease: Role of CB(1) and CB(2) Receptors (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382456/
Prevention of Paclitaxel-Induced Neuropathy Through Activation of the Central
Cannabinoid Type 2 Receptor System (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334436/
Cannabinoid type 2 receptor activation downregulates stroke-induced classic and
alternative brain macrophage/microglial activation concomitant to neuroprotection (full–2012) http://stroke.ahajournals.org/content/43/1/211.long
Neuroprotection by inhibiting the c-Jun N-terminal kinase pathway after cerebral ischemia occurs independently of interleukin-6 and keratinocyte-derived chemokine (KC/CXCL1) secretion (full–2012) http://www.jneuroinflammation.com/content/9/1/76
CB1 cannabinoid receptor activation rescues amyloid β-induced alterations in behaviour and intrinsic electrophysiological properties of rat hippocampal CA1 pyramidal neurones (full–2012) http://www.karger.com/Article/Pdf/338494
WIN55,212-2 protects oligodendrocyte precursor cells in stroke penumbra following permanent focal cerebral ischemia in rats (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4086494/
WIN55, 212-2 promotes differentiation of oligodendrocyte precursor cells and improve remyelination through regulation of the phosphorylation level of the ERK 1/2 via cannabinoid receptor 1 after stroke-induced demyelination (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4086494/
CB1 Agonist ACEA Protects Neurons and Reduces the Cognitive Impairment of AβPP/PS1 Mice (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22451318
Anandamide and 2-arachidonoylglycerol: Pharmacological Properties, Functional Features and Emerging Specificities of the Two Major Endocannabinoids (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22801993
Neuroprotective agents: cannabinoids (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/21420365
Overexpression of CB2 cannabinoid receptors results in neuroprotection against behavioral and neurochemical alterations induced by intracaudate administration of 6-hydroxydopamine (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/20980074
top
Δ(9)-THC exerts a direct neuroprotective effect in a human cell culture model of Parkinson’s disease (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22236282
Single-dose Pharmacokinetics and Tolerability of Oral Delta-9-Tetrahydrocannabinol in Patients with Amyotrophic Lateral Sclerosis (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22594565
Effects of cannabinoids Δ(9)-tetrahydrocannabinol, Δ(9)-tetrahydrocannabinolic acid and cannabidiol in MPP(+) affected murine mesencephalic cultures (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22571976
A cannabinoid type 2 receptor agonist attenuates blood-brain barrier damage and neuro-degeneration in a murine model of traumatic brain injury (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22903455
A Cannabigerol Quinone Alleviates Neuroinflammation in a Chronic Model of Multiple Sclerosis (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22971837
Cannabinoid Receptor Subtypes 1 and 2 Mediate Long-Lasting Neuroprotection and Improve Motor Behaviour Deficits After Transient Focal Cerebral Ischemia (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23069763
Cannabidiol administration after hypoxia-ischemia to newborn rats reduces long-term brain injury and restores neurobehavioral function (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22659086
Specific inhibition of the JNK pathway promotes locomotor recovery and neuro-protection after mouse spinal cord injury (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22426389
The biology that underpins the therapeutic potential of cannabis-based medicines for the control of spasticity in multiple sclerosis (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/25876933
Long-term behavioral and biochemical effects of an ultra-low dose of Δ(9)-tetra-hydrocannabinol (THC): neuroprotection and ERK signaling (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22821081
WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through activation of cannabinoid receptors and PPAR-γ pathway (abst–2012) http://www.sciencedirect.com/science/article/pii/S0028390812001980 NEUROPROTECTIVE EFFECTS OF CANNABIS SATIVA ALCOHOLIC EXTRACT AGAINST SPINAL ALPHA MOTONEURONS DEGENERATION IN MALE TYPE II DIABETIC RATS (abst–2012) http://en.journals.sid.ir/ViewPaper.aspx?ID=278407
Structural and Functional Protection of the Retina by N-Acylethanolamines in Glaucoma (abst–2012) http://iovs.arvojournals.org/article.aspx?articleid=2350521&resultClick=1
Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma (full–2013) http://www.jneuroinflammation.com/content/10/1/20
Using the endocannabinoid system as a neuroprotective strategy in perinatal hypoxic ischemic brain injury (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4146074/
Neuroprotective effects of Cannabis sativa leaves extracts on α-Motoneurons density after sciatic nerve injury in rats (full–2013) http://www.lifesciencesite.com/lsj/life1005s/113_15973life1005s_644_648.pdf
top
HINT1 protein cooperates with cannabinoid 1 receptor to negatively regulate glutamate NMDA receptor activity (full–2013) http://www.molecularbrain.com/content/6/1/42
CB2 Receptor Agonists Protect Human Dopaminergic Neurons against Damage from HIV-1 gp120 (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0077577
Molecular targets underlying SUMO-mediated neuroprotection in brain ischemia (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/jnc.12347/full
A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury (full–2013) http://www.jneuroinflammation.com/content/10/1/91
Selective inhibition of alpha/beta-hydrolase domain 6 attenuates neurodegeneration, alleviates blood brain barrier breakdown, and improves functional recovery in a mouse model of traumatic brain injury (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3636589/
The Influence of Cannabinoids on Generic Traits of Neurodegeneration (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/bph.12492/full
Does the neuroprotective role of anandamide display diurnal variations? (full–2013) http://www.mdpi.com/1422-0067/14/12/23341/htm
Transdermal delivery of cannabidiol attenuates binge alcohol-induced neuro-degeneration in a rodent model of an alcohol use disorder (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4096899/
Neuroimmmune interactions of cannabinoids in neurogenesis: focus on interleukin-1β (IL-1β) signalling (full–2013) http://www.biochemsoctrans.org/content/41/6/1577
CB2 cannabinoid agonist enhanced neurogenesis in GFAP/Gp120 transgenic mice displaying deficits in neurogenesis (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3904265/
Cannabinoids: Do they have the potential to treat the symptoms of multiple sclerosis? (full–2013) http://www.wjgnet.com/2218-6212/full/v3/i4/87.htm
CB1 and CB2 Cannabinoid Receptor Antagonists Prevent Minocycline-Induced Neuroprotection Following Traumatic Brain Injury in Mice (full–2013) http://cercor.oxfordjournals.org/content/25/1/35.long
The neuroprotective effects of cocoa flavanol and its influence on cognitive performance (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575938/
Palmitoylethanolamide in Homeostatic and Traumatic Central Nervous System Injuries (link to PDF-2013) http://www.eurekaselect.com/107976/article
Neuroglial Roots of Neurodegenerative Diseases: Therapeutic Potential of Palmitoylethanolamide in Models of Alzheimer’s Disease (link to PDF–2013) http://www.eurekaselect.com/107977/article
Activation of the CB(2) receptor system reverses amyloid-induced memory deficiency (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/22795792
Nicotine-Induced Neuroprotection Against Ischemic Injury Involves Activation of Endocannabinoid System in Rats (abst–2013) http://link.springer.com/article/10.1007/s11064-012-0927-6
The neuroprotective role of endocannabinoids against chemical-induced injury and other adverse effects (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23296873
Neuroprotective effects of topical CB1 agonist WIN 55212-2 on Retinal ganglion cells after acute rise in intraocular pressure induced ischemia in rat (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23454099
Mechanisms Of Cannabidiol Neuroprotection In Hypoxic-Ischemic Newborn Pigs: Role Of 5HT1A And CB2 Receptors (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23587650
top
Glia and Mast Cells as Targets for Palmitoylethanolamide, an Anti-inflammatory and Neuroprotective Lipid Mediator (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23813098
Palmitoylethanolamide is a new possible pharmacological treatment for the inflammation associated with trauma (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/22697514
CB1 and CB2 Cannabinoid Receptor Antagonists Prevent Minocycline-Induced Neuro-protection Following Traumatic Brain Injury in Mice (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23960212
Neuroprotection and reduction of glial reaction by cannabidiol treatment after sciatic nerve transection in neonatal rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23981015
Cannabinoid Effects on β Amyloid Fibril and Aggregate Formation, Neuronal and Microglial-Activated Neurotoxicity In Vitro (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24030360
Activation of STAT3 is involved in neuroprotection by electroacupuncture pre-treatment via cannabinoid CB1 receptors in rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23880371
Δ9-Tetrahydrocannabinol is protective through PPARγ dependent mitochondrial bio-genesis in a cell culture model of Parkinson’s Disease (abst–2013) http://jnnp.bmj.com/content/84/11/e2.58.abstract
Cannabidiol Promotes Amyloid Precursor Protein Ubiquitination and Reduction of Beta Amyloid Expression in SHSY5YAPP+ Cells Through PPARγ Involvement (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24288245
The Cannabinoid Agonist HU210 Delays Retinal Degeneration and Vision (abst-2013) http://iovs.arvojournals.org/article.aspx?articleid=2148029&resultClick=1
Δ9-tetrahydrocannabinol prevents methamphetamine-induced neurotoxicity (full-2014) http://www.plosone.org/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0098079&representationDF
The endocannabinoid system: a putative role in neurodegenerative diseases (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4070159/
A restricted population of CB1 cannabinoid receptors with neuroprotective activity (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4050577/
Cannabinoids: well-suited candidates for the treatment of perinatal brain injury (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4061885/
Anandamide Protects HT22 Cells Exposed to Hydrogen Peroxide by Inhibiting CB1 Receptor-Mediated Type 2 NADPH Oxidase (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4127243/
Cannabinoid CB2 receptor (CB2R) stimulation delays rubrospinal mitochondrial-dependent degeneration and improves functional recovery after spinal cord hemi-section by ERK1/2 inactivation (full–2014) http://www.nature.com/cddis/journal/v5/n9/full/cddis2014364a.html
Glucose concentration in culture medium affects mRNA expression of TRPV1 and CB1 receptors and changes capsaicin toxicity in PC12 cells (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4322151/
Palmitoylethanolamide controls reactive gliosis and exerts neuroprotective functions in a rat model of Alzheimer’s disease (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25210802
top
Palmitoylethanolamide controls reactive gliosis and exerts neuroprotective functions in a rat model of Alzheimer’s disease (full–2014) http://www.nature.com/cddis/journal/v5/n9/full/cddis2014376a.html
Regulatory role of the Cannabinoid-2 receptor in stress-induced neuroinflammation in mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24467609
Endocannabinoid signalling and the deteriorating brain (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471876/
Hypoximimetic activity of N-acyl-dopamines. N-arachidonoyl-dopamine stabilizes HIF-1α protein through a SIAH2-dependent pathway (full–2014) http://www.sciencedirect.com/science/article/pii/S0167488914002821
Changes in Endocannabinoid Receptors and Enzymes in the Spinal Cord of SOD1G93A Transgenic Mice and Evaluation of a Sativex®-like Combination of Phytocannabinoids: Interest for Future Therapies in Amyotrophic Lateral Sclerosis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24703394
Changes in Endocannabinoid Receptors and Enzymes in the Spinal Cord of SOD1G93A Transgenic Mice and Evaluation of a Sativex®-like Combination of Phytocannabinoids: Interest for Future Therapies in Amyotrophic Lateral Sclerosis (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/cns.12262/full
Neuroprotective Properties of Cannabigerol in Huntington’s Disease: Studies in R6/2 Mice and 3-Nitropropionate-lesioned Mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25252936
Neuroprotective Properties of Cannabigerol in Huntington’s Disease: Studies in R6/2 Mice and 3-Nitropropionate-lesioned Mice (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4322067/
The fatty acid amide hydrolase inhibitor PF-3845 promotes neuronal survival, attenuates inflammation and improves functional recovery in mice with traumatic brain injury (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4437642/
Impaired Neurogenesis by HIV-1-Gp120 is Rescued by genetic deletion of Fatty Acid Amide Hydrolase Enzyme (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4594266/
Normal aging in rats and pathological aging in human Alzheimer disease decrease FAAH activity: Modulation by cannabinoid agonists (full–2014) http://www.sciencedirect.com/science/article/pii/S0531556514002903
Endocannabinoid degradation inhibition improves neurobehavioral function, blood brain barrier integrity, and neuroinflammation following mild traumatic brain injury (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25166905
Endocannabinoid degradation inhibition improves neurobehavioral function, blood brain barrier integrity, and neuroinflammation following mild traumatic brain injury (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348366/
Prior stimulation of the endocannabinoid system prevents methamphetamine-induced dopaminergic neurotoxicity in the striatum through activation of CB2 receptors (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24709540
Prior stimulation of the endocannabinoid system prevents methamphetamine-induced dopaminergic neurotoxicity in the striatum through activation of CB2 receptors (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939842/
Endocannabinoids in Synaptic Plasticity and Neuroprotection (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24571856
Endocannabinoids in Synaptic Plasticity and Neuroprotection (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4143501/
Cannabinoid receptor activation inhibits cell cycle progression by modulating 14-3-3β (link to PDF–2014) http://www.degruyter.com/view/j/cmble.2014.19.issue-3/s11658-014-0200-x/s11658-014-0200-x.xml
Cannabidiol Normalizes Capase 3, Synatophsin, and Mitochondrial Fission Protein DNM1L Expression Levels in Rats with Brain Iron Overload: Implications for Neuro-protection (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/23893294
Trans-Caryophyllene Suppresses Hypoxia-Induced Neuroinflammatory Responses by Inhibiting NF-κB Activation in Microglia (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24488604
Neuroprotective effects of the cannabinoid agonist HU210 on retinal degeneration (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24495949
Endocannabinoid 2-Arachidonylglycerol Protects Primary Cultured Neurons Against LPS-Induced Impairments in Rat Caudate Nucleus (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24510751
Effect of N-Arachidonoyl Dopamine on Activity of Neuronal Network in Primary Hippocampus Culture upon Hypoxia Modelling (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24771427
top
Functions of the CB1 and CB 2 Receptors in Neuroprotection at the Level of the Blood-Brain Barrier (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24929655
The monoacylglycerol lipase inhibitor JZL184 is neuroprotective and alters glial cell phenotype in the chronic MPTP mouse model (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24973119
Endocannabinoid 2-Arachidonylglycerol Protects Primary Cultured Neurons Against Homocysteine-Induced Impairments in Rat Caudate Nucleus Through CB1 Receptor (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25007951
Cannabinoid Receptor-2 and HIV-Associated Neurocognitive Disorders (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25015040
Ultralow doses of cannabinoid drugs protect the mouse brain from inflammation-induced cognitive damage (abst–2014) http://onlinelibrary.wiley.com/doi/10.1002/jnr.23452/abstract
Protective effects of cannabidiol against hippocampal cell death and cognitive impairment induced by bilateral common carotid artery occlusion in mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24532152
Chronic cannabinoid receptor stimulation selectively prevents motor impairments in a mouse model of Huntington’s disease (abst–2014)
http://www.ncbi.nlm.nih.gov/pubmed/25123645
Distinct modulation of the endocannabinoid system upon kainic acid-induced in vivo seizures and in vitro epileptiform bursting (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25064144
Cannabinoid-mediated short-term plasticity in hippocampus (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25123173
Mn-SOD Upregulation by Electroacupuncture Attenuates Ischemic Oxidative Damage via CB1R-Mediated STAT3 Phosphorylation (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25432886
Magnolol protects neurons against ischemia injury via the downregulation of p38/MAPK, CHOP and nitrotyrosine (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25038313
Neuroprotection by association of palmitoylethanolamide with luteolin in experimental Alzheimer’s disease models: the control of neuroinflammation (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25106636
Rising stars: Modulation of brain functions by astroglial type-1 cannabinoid receptors (abst–2014 http://www.ncbi.nlm.nih.gov/pubmed/25452006
Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1∆E9 mice (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24577515
The Association Between Normal Optic Nerve Cupping , Normal Visual Fields and Marijuana Use (abst–2014) http://iovs.arvojournals.org/article.aspx?articleid=2271290&resultClick=1
Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cells (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/apha.12474/full
The CB1 cannabinoid receptor signals striatal neuroprotection via a PI3K / Akt / mTORC1 / BDNF pathway (full–2015) http://www.nature.com/cdd/journal/vaop/ncurrent/full/cdd201511a.html
Palmitoylethanolamide Inhibits Glutamate Release in Rat Cerebrocortical Nerve Terminals (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4394492/
Perinatal asphyxia results in altered expression of the hippocampal acylethanolamide / endocannabinoid signaling system associated to memory impairments in postweaned rats (full–2015) http://journal.frontiersin.org/article/10.3389/fnana.2015.00141/full
New horizons for newborn brain protection: enhancing endogenous neuroprotection (full–2015) http://fn.bmj.com/content/early/2015/06/10/archdischild-2014-306284.long
Alcohol Versus Cannabinoids: A Review of Their Opposite Neuro-Immunomodulatory Effects and Future Therapeutic Potentials (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607066/
Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26244281
Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease (full–2015) http://www.sciencedirect.com/science/article/pii/S0014488615300583
A new formulation of cannabidiol in cream shows therapeutic effects in a mouse model of experimental autoimmune encephalomyelitis (full–2015) http://darujps.biomedcentral.com/articles/10.1186/s40199-015-0131-8
Are the endocannabinoid-like compounds N-acyl aminoacids neuroprotective after traumatic brain injury? (full–2015) http://www.degruyter.com/view/j/jbcpp.ahead-of-print/jbcpp-2015-0092/jbcpp-2015-0092.xml
HU-446 and HU-465, derivatives of the non-psychoactive cannabinoid cannabidiol, decrease the activation of encephalitogenic T cells (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/cbdd.12637/full
Mitochondrial CB1 receptor is involved in ACEA-induced protective effects on neurons and mitochondrial functions (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26215450
Mitochondrial CB1 receptor is involved in ACEA-induced protective effects on neurons and mitochondrial functions (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516969/
The therapeutic potential of cannabinoids for movement disorders (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25649017
Enhancement of endocannabinoid signalling protects against cocaine-induced neurotoxicity (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25933444
A sativex-like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25857324
Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26260390
Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604192/ Endogenous 2-Arachidonoylglycerol Alleviates Cyclooxygenases-2 Elevation-Mediated Neuronal Injury from SO2 Inhalation via PPARγ Pathway (full–2015) http://toxsci.oxfordjournals.org/content/147/2/535.long
Cannabinoid receptor type 1 agonist ACEA improves motor recovery and protects neurons in ischemic stroke in mice (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/jnc.13288/full
Purified Cannabidiol, the main non-psychotropic component of Cannabis sativa, alone, counteracts neuronal apoptosis in experimental multiple sclerosis (link to PDF–2015) http://www.europeanreview.org/article/10049
On the Role of Astroglial Syncytia in Self-Repairing Spiking Neural Networks (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25576582
Cannabidiol increases survival and promotes rescue of cognitive function in a murine model of Cerebral Malaria (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25595981
N-stearoyltyrosine protects primary cortical neurons against Aβ(1-40)-induced injury through inhibiting endocannabinoid degradation (abst-2015) http://www.sciencedirect.com/science/article/pii/S0024320515000521
Palmitoyl Serine: An Endogenous Neuroprotective Endocannabinoid-Like Entity After Traumatic Brain Injury (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25721934
Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 suppress chronic cerebral hypoperfusion-induced neuronal apoptosis by inhibiting c-Jun N-terminal kinase signaling (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25795598
Elevation of Plasma 2-Arachidonoylglycerol Levels in Alzheimer’s Disease Patients as a Potential Protective Mechanism against Neurodegenerative Decline (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25818503
Monoacylglycerol Lipase Inhibitor Protects Primary Cultured Neurons Against Homocysteine-induced Impairments in Rat Caudate Nucleus through COX-2 signaling (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25818189
Protective effect of paeoniflorin on the hippocampus in rats with cerebral ischemia reperfusion through activating cannabinoid receptor 2 (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25854559
Potential of the cannabinoid CB2 receptor as a pharmacological target against inflammation in Parkinson’s disease (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25863279
Endocannabinoids regulate the activity of astrocytic hemichannels and the microglial response against an injury: In vivo studies (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25917763
The effect of endocannabinoid system in ischemia-reperfusion injury: a friend or a foe?  (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25936364
top
Cannabinoid receptor 2 attenuates microglial accumulation and brain injury following germinal matrix hemorrhage via ERK dephosphorylation in vivo and in vitro (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25963415
Neuroprotective Effect of JZL184 in MPP+-Treated SH-SY5Y Cells Through CB 2 Receptors  (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25976369
Synthetic and endogenous cannabinoids protect retinal neurons from AMPA excitotoxicity in vivo, via activation of CB1 receptors: Involvement of PI3K/Akt and MEK/ERK signaling pathways (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25989217
N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26055231
Combined neuroprotective action of adenosine A1 and cannabinoid CB1 receptors against NMDA-induced excitotoxicity in the hippocampus (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26065937
Effect of Homocysteine on Voltage-Gated Sodium Channel Currents in Primary Cultured Rat Caudate Nucleus Neurons and Its Modulation by 2-Arachidonylglycerol (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26179279
top
Neuroprotective mechanisms of cannabinoids in brain ischemia and neurodegenerative disorders (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26299059
Endocannabinoids in Multiple Sclerosis and Amyotrophic Lateral Sclerosis (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26408162
Endocannabinoids and Neurodegenerative Disorders: Parkinson’s Disease, Huntington’s Chorea, Alzheimer’s Disease, and Others (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26408163
N-Palmitoyl serotonin alleviates scopolamine-induced memory impairment via regulation of cholinergic and antioxidant systems, and expression of BDNF and p-CREB in mice (abst–2015) http://www.sciencedirect.com/science/article/pii/S0009279715300697
The effect of WIN 55,212-2 suggests a cannabinoid-sensitive component in the early toxicity induced by organic acids accumulating in glutaric acidemia type I and in related disorders of propionate metabolism in rat brain synaptosomes (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26431622
Neuroprotective Effect Is Driven Through the Upregulation of CB1 Receptor in Experimental Autoimmune Encephalomyelitis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26411568
The neuroprotection of cannabidiol against MPP+-induced toxicity in PC12 cells involves trkA receptors, upregulation of axonal and synaptic proteins, neuritogenesis, and might be relevant to Parkinson’s disease (abst–2015) http://www.sciencedirect.com/science/article/pii/S0887233315300047
THC exerts neuroprotective effect in glutamate affected murine primary mesencephalic cultures and neuroblastoma N18TG2 cells (abst–2015) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0035-1565754
Cannabidiol protects an in vitro model of the blood brain barrier (BBB) from oxygen-glucose deprivation via PPARγ and 5-HT1A (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26497782
Ultra-low doses of tetrahydrocannabinol contribute to the survival of newly-born cells in the dentate gyrus of adult rats (abst–2015)
http://link.springer.com/article/10.1134/S1819712415030046
Cannabinoid CB2 Receptor Mediates Nicotine-Induced Anti-Inflammation in N9 Microglial Cells Exposed to β Amyloid via Protein Kinase C (full–2016) http://www.hindawi.com/journals/mi/2016/4854378/
The Endocannabinoid System as a Therapeutic Target in Glaucoma (full–2016) http://www.hindawi.com/journals/np/2016/9364091/
NO2 inhalation promotes Alzheimer’s disease-like progression: cyclooxygenase-2- derived prostaglandin E2 modulation and monoacylglycerol lipase inhibition-targeted medication (full–2016) http://www.nature.com/articles/srep22429
CB2 cannabinoid receptor is involved in the anti-inflammatory effects of leptin in a model of traumatic brain injury (full–2016) http://www.sciencedirect.com/science/article/pii/S0014488616300619
Natural Phytochemicals in the Treatment and Prevention of Dementia: An Overview (full–2016) http://www.mdpi.com/1420-3049/21/4/518/htm
Cannabinoid 1 receptor knockout mice display cold allodynia, but enhanced recovery from spared-nerve injury-induced mechanical hypersensitivity (full–2016) http://mpx.sagepub.com/content/12/1744806916649191.long B2 Cannabinoid Receptor As Potential Target against Alzheimer’s Disease (full–2016) http://journal.frontiersin.org/article/10.3389/fnins.2016.00243/full#B36
Amyloid proteotoxicity initiates an inflammatory response blocked by cannabinoids (full–2016) http://www.nature.com/articles/npjamd201612
Delta-9-tetrahydrocannabinol protects against MPP+ toxicity in SH-SY5Y cells by restoring proteins involved in mitochondrial biogenesis (full–2016) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path %5B%5D=10314&path%5B%5D=32486
The Cannabinoid CB1/CB2 Agonist WIN55212.2 Promotes Oligodendrocyte Differentiation In Vitro and Neuroprotection During the Cuprizone-Induced Central Nervous System Demyelination (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/cns.12506/full
Neuroprotective effect of endogenous cannabinoids on ischemic brain injury induced by the excess microglia-mediated inflammation (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931157/
VCE-003.2, a novel cannabigerol derivative, enhances neuronal progenitor cell survival and alleviates symptomatology in murine models of Huntington’s disease (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4949444/
Orchestrated activation of mGluR5 and CB1 promotes neuroprotection (full–2016) http://molecularbrain.biomedcentral.com/articles/10.1186/s13041-016-0259-6
Cannabinoid Type 2 (CB2) Receptors Activation Protects against Oxidative Stress and Neuroinflammation Associated Dopaminergic Neurodegeneration in Rotenone Model of Parkinson’s Disease (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969295/
Mild Traumatic Brain Injury Produces Neuron Loss That Can Be Rescued by Modulating Microglial Activation Using a CB2 Receptor Inverse Agonist (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052277/
CB2 receptor activation prevents glial-derived neurotoxic mediator production, BBB leakage and peripheral immune cell infiltration and rescues dopamine neurons in the MPTP model of Parkinson’s disease (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4892852/
Target regulation of PI3K/Akt/mTOR pathway by cannabidiol in treatment of experimental multiple sclerosis (full–2016) http://www.sciencedirect.com/science/article/pii/S0367326X16304476
Cannabidiol attenuates OGD/R-induced damage by enhancing mitochondrial bioenergetics and modulating glucose metabolism via pentose-phosphate pathway in hippocampal neurons (full–2016) http://www.sciencedirect.com/science/article/pii/S221323171630338X
Cannabidiol Post-Treatment Alleviates Rat Epileptic-Related Behaviors and Activates Hippocampal Cell Autophagy Pathway Along with Antioxidant Defense in Chronic Phase of Pilocarpine-Induced Seizure (abst–2016) http://link.springer.com/article/10.1007/s12031-015-0703-6 Mn-SOD
Upregulation by Electroacupuncture Attenuates Ischemic Oxidative Damage via CB1R-Mediated STAT3 Phosphorylation (abst–2016) http://link.springer.com/article/10.1007/s12035-014-8971-7
Prior Cannabis Use Is Associated with Outcome after Intracerebral Hemorrhage (abst-2016) http://www.ncbi.nlm.nih.gov/pubmed/26820826
Arachidonyl-2-Chloroethylamide Alleviates Cerebral Ischemia Injury Through Glycogen Synthase Kinase-3β-Mediated Mitochondrial Biogenesis and Functional Improvement. (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26820679
Cannabidiol, neuroprotection and neuropsychiatric disorders (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816000396
Involvement of TRPV1 channels in the activity of the cannabinoid WIN 55,212-2 in an acute rat model of temporal lobe epilepsy (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26970948
Cannabinoids Occlude the HIV-1 Tat-Induced Decrease in GABAergic Neurotransmission in Prefrontal Cortex Slices (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26993829
Endocannabinoid 2-Arachidonoylglycerol Suppresses LPS-Induced Inhibition of A-Type Potassium Channel Currents in Caudate Nucleus Neurons Through CB1 Receptor (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27129498
Stimulated CB1 Cannabinoid Receptor Inducing Ischemic Tolerance and Protecting Neuron from Cerebral Ischemia (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27142423
Inhibition of Endocannabinoid Degradation Improves Outcomes from Mild Traumatic Brain Injury: A Mechanistic Role for Synaptic Hyperexcitability (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27189876
Activity of muscarinic, galanin and cannabinoid receptors in the prodromal and advanced stages in the triple transgenic mice model of Alzheimer’s disease (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27223629
Upregulation of the cannabinoid CB2 receptor in environmental and viral inflammation driven rat models of Parkinson’s disease (abst–2016) http://www.sciencedirect.com/science/article/pii/S0014488616301790
Cannabinoid receptor agonism suppresses tremor, cognition disturbances and anxiety-like behaviors in a rat model of essential tremor (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27317835
Fatty acid amide hydrolase inhibition for the symptomatic relief of Parkinsons disease (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27318096
Cannabinoids and Neuro-Inflammation: Regulation of Brain Immune Response (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27334610
The bright side of psychoactive substances: cannabinoid-based drugs in motor diseases (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27373318
Inhibitors of diacylglycerol lipases in neurodegenerative and metabolic disorders (abst–2016) http://www.sciencedirect.com/science/article/pii/S0960894X16306874
A study of cannabinoid-1 receptors during the early phase of excitotoxic damage to rat spinal locomotor networks in vitro (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27450568
Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 may protect against cognitive impairment in rats of chronic cerebral hypoperfusion via PI3K/AKT signaling (abst–2016) http://www.sciencedirect.com/science/article/pii/S0166432816304375
The cannabinoid receptor agonist WIN55.212 reduces consequences of status epilepticus in rats (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27520083
Anandamide reverses depressive-like behavior, neurochemical abnormalities and oxidative-stress parameters in streptozotocin-diabetic rats: Role of CB1 receptors (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27544303
Neuroprotective Effects of Cannabidiol In Hypoxic Ischemic Insult: The Therapeutic Window In Newborn Mice (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27686886
Gingival Stromal Cells as an In Vitro Model: Cannabidiol Modulates Genes Linked with Amyotrophic Lateral Sclerosis (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27714895
Activation of Cannabinoid Receptor 2 Attenuates Mechanical Allodynia and Neuroinflammatory Responses in a Chronic Post-Ischemic Pain Model of Complex Regional Pain Syndrome Type I in Rats (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27717112
Cannabinoids prevent the amyloid β-induced activation of astroglial hemichannels: A neuroprotective mechanism (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27757991
The cannabinoid beta-caryophyllene (BCP) induces neuritogenesis in PC12 cells by a cannabinoid-receptor-independent mechanism (abst–2016) http://www.sciencedirect.com/science/article/pii/S0009279716305920
Cannabidiol reduces neuroinflammation and promotes neuroplasticity and functional recovery after brain ischemia (abst–2016) http://www.sciencedirect.com/science/article/pii/S0278584616302524
The arguments for and against cannabinoids application in glaucomatous retinopathy (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28027538 Up-regulation of CB2 receptors in reactive astrocytes in canine degenerative myelopathy, a disease model of amyotrophic lateral sclerosis (full–2017) http://dmm.biologists.org/content/early/2017/01/06/dmm.028373.long
Effect of inhibition of fatty acid amide hydrolase on MPTP-induced dopaminergic neuronal damage (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28104279
Endocannabinoid 2-arachidonoylglycerol protects inflammatory insults from sulfur dioxide inhalation via cannabinoid receptors in the brain (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28115138
top


NUTRITION-GENERAL
Exposure to a high-fat diet decreases sensitivity to Δ9-tetrahydrocannabinol-induced motor effects in female rats (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3014410/
Cannabis as a Unique Functional Food (full–2011) http://apothecary-genetics.spruz.com/gfile/75r4!-!HLKELE!-!svyr5/cannabis_as_a_unique_functional_food.pdf
Hemp Food Storage (article–2012) http://www.innvista.com/health/foods/hemp/hemp-food-storage/
Changes on metabolic parameters induced by acute cannabinoid administration (CBD, THC) in a rat experimental model of nutritional vitamin A deficiency (full–2013) http://www.nutricionhospitalaria.com/pdf/6430.pdf
Nutritional omega-3 modulates neuronal morphology in the prefrontal cortex along with depression-related behaviour through corticosterone secretion (full–2014) http://www.nature.com/tp/journal/v4/n9/full/tp201477a.html
Endocannabinoid signaling and its regulation by nutrients (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24753395
Developmentally vitamin D-deficient rats show enhanced prepulse inhibition after acute Δ9-tetrahydrocannabinol (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24776491
Characterization of Byproducts Originating from Hemp Oil Processing (abst–2014) http://pubs.acs.org/doi/abs/10.1021/jf5044426
Maternal Caloric Restriction Implemented during the Preconceptional and Pregnancy Period Alters Hypothalamic and Hippocampal Endocannabinoid Levels at Birth and Induces Overweight and Increased Adiposity at Adulthood in Male Rat Offspring (full–2016) http://journal.frontiersin.org/article/10.3389/fnbeh.2016.00208/full
Exposure to a Highly Caloric Palatable Diet during the Perinatal Period Affects the Expression of the Endogenous Cannabinoid System in the Brain, Liver and Adipose Tissue of Adult Rat Offspring (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0165432
Long-Term Effects of Prenatal Exposure to Undernutrition on Cannabinoid Receptor Related Behaviors: Sex and Tissue-Specific Alterations in the mRNA Expression of Cannabinoid Receptors and Lipid Metabolic Regulators (full–2016) http://journal.frontiersin.org/article/10.3389/fnbeh.2016.00241/full
Lipids in psychiatric disorders and preventive medicine (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763415303353
Fabp1 gene ablation inhibits high fat diet-induced increase in brain endocannabinoids (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27861894
Cannabimimetic phytochemicals in the diet – an evolutionary link to food selection and metabolic stress adaptation? (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27891602
Peripheral endocannabinoid signaling controls hyperphagia in western diet-induced obesity (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28065722


NUTRITION-HEMP SEED
MATERIAL SAFETY AND DATA SHEET FOR CANAH HEMP SEED FLOUR (full-undated) https://canah.com/pdf/specificatii/Technical-Specification-Hemp-Seed-Flour.pdf
The cardiac and haemostatic effects of dietary hempseed (full–2010) http://www.nutritionandmetabolism.com/content/pdf/1743-7075-7-32.pdf
Effects of increasing amounts of hempseed cake in the diet of dairy cows on the production and composition of milk (full–2010) http://journals.cambridge.org/action/displayFulltext?type=6&fid=7909529&jid=ANM&volumeId=4&issueId=11&aid=7909528&bodyId=&membershipNumber=&societyETOCSession=&fulltextType=RA&fileId=S1751731110001254
top
Influence of Feed Supplementation with Cannabis Sativa on Quality of Broilers Carcass (full–2010) http://www.pvj.com.pk/pdf-files/30_1/34-38.pdf
Information on Chia, Hemp & Flax (article–2010) http://www.ehow.com/facts_7460031_information-chia_-hemp-flax.html
Dietary intakes in a group of marihuana smoking patients (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20694309
Evaluating the Quality of Protein from Hemp Seed (Cannabis sativa L.) Products Through the use of the Protein Digestibility-Corrected Amino Acid Score Method (abst–2010) http://pubs.acs.org/doi/abs/10.1021/jf102636b
Efficacy of a Chinese herbal proprietary medicine (Hemp Seed Pill) for functional constipation (full–2011) http://www.nature.com/ajg/journal/v106/n1/pdf/ajg2010305a.pdf
The effects of hempseed meal intake and linoleic acid on Drosophila models of neurodegenerative diseases and hypercholesterolemia (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933972/
Isolation and Characterization of Edestin from Cheungsam Hempseed (link to PDF–2011) http://koreascience.or.kr/article/ArticleFullRecord.jsp? cn=E1OOBF_2011_v54n2_84
The effect of dietary hempseed on atherogenesis and contractile function in aortae from hypercholesterolemic rabbits (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21893466
Distinctive effects of plant protein sources on renal disease progression and associated cardiac hypertrophy in experimental kidney disease (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21294251
Searching for health beneficial n-3 and n-6 fatty acids in plant seeds (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3380567/?toolubmed
Archaeobotanical study of ancient food and cereal remains at the Astana cemeteries, Xinjiang, China (full–2012) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0045137
Nutritive quality of romanian hemp varieties (Cannabis sativa L.) with special focus on oil and metal contents of seeds (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3543203/
Effect of feeding hemp seed and hemp seed oil on laying hen performance and egg yolk fatty acid content: Evidence of their safety and efficacy for laying hen diets (full–2012) http://ps.oxfordjournals.org/content/91/3/701.long
Comparative Study of Sedation, Pre-Anesthetic and Anti-Anxiety Effects of Hemp Seed Extract and Diazepam in Rats (full–2012) http://docsdrive.com/pdfs/medwelljournals/javaa/2012/2148-2151.pdf
Hemp Food Storage (article–2012) http://www.innvista.com/health/foods/hemp/hemp-food-storage/
Hemp Seed Protein (article–2012) http://www.innvista.com/foods/hemp/hemp-seed-protein/
Hemp Seeds (article–2012) http://www.innvista.com/foods/hemp/hemp-seeds/
Hemp Seeds as Medicine (article–2012) http://www.innvista.com/foods/hemp/hemp-seeds-as-medicine/
Proteomic profiling of hempseed proteins from Cheungsam (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22040604
Fatty Acid Profile and Sensory Characteristics of Table Eggs from Laying Hens Fed Hempseed and Hempseed Oil (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22429187
top
The isolation and identification of two compounds with predominant radical scavenging activity in hempseed (seed of Cannabis sativa L.) (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23107724
Agents that act luminally to treat diarrhoea and constipation (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22945441
EFFECTS OF GRADED LEVELS OF HEMP SEED (CANNABIS SATIVA L.) ON PERFORMANCE, ORGAN WEIGHT AND SERUM CHOLESTEROL LEVELS ON BROILERS (abst–2012) http://en.journals.sid.ir/ViewPaper.aspx?ID=276824
Association of Expanded Disability Status Scale and Cytokines after Intervention with Co-supplemented Hemp Seed, Evening Primrose Oils and Hot-natured Diet in Multiple Sclerosis Patients (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3648912/
Preventive and treatment effects of a hemp seed (Cannabis sativa L.) meal protein hydrolysate against high blood pressure in spontaneously hypertensive rats (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/24292743
A novel hemp seed meal protein hydrolysate reduces oxidative stress factors in spontaneously hypertensive rats (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4276990/
Molecular characterization of edestin gene family in Cannabis sativa L. (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25280223
Activity of liver enzymes in multiple sclerosis patients with Hot-nature diet and cosupplemented hemp seed, evening primrose oils intervention (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25453518
Structural and functional characterization of hemp seed (Cannabis sativa L.) protein derived antioxidant and antihypertensive peptides (abst–2014) http://www.sciencedirect.com/science/article/pii/S1756464613002594
Structural and functional properties of hemp seed protein products (abst–2014) https://www.ncbi.nlm.nih.gov/pubmed/25048774
Characterization of Lignanamides from Hemp (Cannabis sativa L.) Seed and their Antioxidant and Acetylcholinesterase Inhibitory Activities (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26585089
Denaturation and Oxidative Stability of Hemp Seed (Cannabis sativa L.) Protein Isolate as Affected by Heat Treatment (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26142888
Alteration of delta-6-desaturase (FADS2), secretory phospholipase-A2 (sPLA2) enzymes by Hot-nature diet with co-supplemented hemp seed, evening primrose oils intervention in multiple sclerosis patients (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26365444
Effect of Hempseed (Cannabis sativa sp.) Inclusion to the Diet on Performance, Carcass and Antioxidative Activity in Japanese Quail (Coturnix coturnix japonica) (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4597843/
Variability in Seed Traits in a Collection of Cannabis sativa L. Genotypes (full-2016) http://journal.frontiersin.org/article/10.3389/fpls.2016.00688/full
Effects of Different Levels of Hemp Seed (Cannabis Sativa L.) and Dextran Oligosaccharide on Growth Performance and Antibody Titer Response of Broiler Chickens (full–2016) http://www.tandfonline.com/doi/full/10.4081/ijas.2015.3473
Proteomic characterization of hempseed (Cannabis sativa L.) (abst–2016) http://www.sciencedirect.com/science/article/pii/S1874391916302354
Seed composition of ten industrial hemp cultivars approved for production in Canada (abst–2016) http://www.sciencedirect.com/science/article/pii/S088915751400194X
Determination of cannabinoids in hemp nuts products in Taiwan by HPLC-MS/MS coupled with chemometric analysis: Quality evaluation and a pilot human study (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27590030
Textual research on Han-Chinese formulae collected in Tubo medical manuscript unearthed in ‘Bum-pa-Che Tower (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28103984


NUTRITION-HEMP SEED OIL
QUALITY OF HEMP SEED OIL DEPENDING ON ITS OBTAINING (abst–2010) http://www.potravinarstvo.com/journal1/index.php/potravinarstvo/article/view/32/pdf
Evaluating the quality of protein from hemp seed (Cannabis sativa L.) products through the use of the protein digestibility-corrected amino acid score method (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20977230
Analytical Characterization of Hempseed (Seed of Cannabis sativa L.) Oil from Eight Regions in China (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/22435611
top
Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21278728
Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions. Figure 1: n-3/n-6 PUFA dietary imbalance alters PUFAs level in mouse brain (charts–2011) http://www.nature.com/neuro/journal/v14/n3/fig_tab/nn.2736_F1.html
Searching for health beneficial n-3 and n-6 fatty acids in plant seeds (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3380567/
Antioxidant Activities and Oxidative Stabilities of Some Unconventional Oilseeds (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3311859/?toolubmed
Effect of feeding hemp seed and hemp seed oil on laying hen performance and egg yolk fatty acid content: Evidence of their safety and efficacy for laying hen diets (full–2012) http://ps.oxfordjournals.org/content/91/3/701.long
Fatty Acid Profile and Sensory Characteristics of Table Eggs from Laying Hens Fed Hempseed and Hempseed Oil (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22429187
Nutritional suitability of linseed and oil hemp from fatty acids profile perspective (abst–2012) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0032-1320816
Chemical Composition and Characterization of Hemp (Cannabis sativa) Seed oil and essential fatty acids by HPLC Method (full–2013) http://scholarsresearchlibrary.com/aasr-vol5-iss1/AASR-2013-5-1-5-8.pdf
Targeted mutation of Δ12 and Δ15 desaturase genes in hemp produce major alterations in seed fatty acid composition including a high oleic hemp oil (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24506492
Targeted mutation of Δ12 and Δ15 desaturase genes in hemp produce major alterations in seed fatty acid composition including a high oleic hemp oil (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/pbi.12167/full
Hemp (Cannabis sativa L.) seed oil: Analytical and phytochemical characterization of unsaponifiable fraction (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24422510
Effects of Hemp (Cannabis sativa L.) Seed Oil Press-Cake and Decaffeinated Green Tea Leaves (Camellia sinensis) on Functional Characteristics of Gluten-Free Crackers (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24527987
Potential Oil Yield, Fatty Acid Composition, and Oxidation Stability of the Hempseed Oil from Four Cannabis sativa L. Cultivars (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24552275
Hempseed oil induces reactive oxygen species- and C/EBP homologous protein-mediated apoptosis in MH7A human rheumatoid arthritis fibroblast-like synovial cells (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24814038
Cannabinoid-free Cannabis sativa L. grown in the Po valley: evaluation of fatty acid profile, antioxidant capacity and metabolic content (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24934168
Relationship between cannabinoids content and composition of fatty acids in hempseed oils (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25306338
Characterization of Byproducts Originating from Hemp Oil Processing (abst–2014) http://pubs.acs.org/doi/abs/10.1021/jf5044426
Effect of ultrasound pre-treatment of hemp (Cannabis sativa L.) seed on super-critical CO2 extraction of oil (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25745251
Stability of cosmetic emulsion containing different amount of hemp oil (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25704610
Effect-directed analysis of cold-pressed hemp, flax and canola seed oils by planar chromatography linked with (bio)assays and mass spectrometry (abst–2015) http://www.sciencedirect.com/science/article/pii/S0308814615005890
top
Variability in Seed Traits in a Collection of Cannabis sativa L. Genotypes (full-2016) http://journal.frontiersin.org/article/10.3389/fpls.2016.00688/full
Polyphenolic Compounds and Antioxidant Activity of Cold-Pressed Seed Oil from Finola Cultivar of Cannabis sativa L. (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27076277
Cannabinoid Poisoning by Hemp Seed Oil in a Child (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27299295


NUTRITION-HEMP SEED PROTEIN ISOLATES/POWDERS
Stable Binding of Alternative Protein-enriched Food Matrices with Concentrated Cranberry Bioflavonoids for Functional Food Applications (full–2013) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3769697/

Advertisements